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ABSTRACT OF THE DISSERTATION 
Role of Astrocyte Network in Edema after Juvenile Traumatic 
Brain Injury 
 
by 
 
Andrew Minoru Fukuda 
Doctor of Philosophy, Graduate Program in Physiology 
Loma Linda University, September 2014 
Dr. Jerome Badaut, Chairperson 
 
Juvenile traumatic brain injury (jTBI) is the leading cause of death and disability 
in young children and adolescents. Despite its lasting detrimental effects on the 
developing brain, no pharmacological treatment exists. One of the pathological hallmarks 
of jTBI is edema. Astrocytes play a key role in the edema process, and have been 
hypothesized that numerous astrocyte networks allow communication and propagation of 
edema and secondary injury spread. Two key astrocyte proteins are hypothesized to have 
a central role in the edema process: Aquaporin 4 (AQP4) and Connexin 43 (Cx43). AQP4 
is expressed extensively in astrocyte endfeet, which surrounds the blood vessels as part of 
the blood brain barrier (BBB). Cx43 is central in astrocyte to astrocyte connection and 
communication. We hypothesized that AQP4 acted as one of the potential passageway of 
water into the astrocyte, whereas Cx43 acted as the bridge between astrocytes once inside 
the brain. By blocking these strategically located pathways, we hypothesized that edema 
would decrease post-jTBI. In order to achieve specific inhibitions of APQ4 or Cx43, we 
utilized small interference RNA (siRNA), which is also an endogenous mechanism.  
We observed that after jTBI both AQP4 and Cx43 was significantly upregulated, 
edema was prominent, and reactive astrogliosis occurred. When siAQP4 was 
xv 
administered after jTBI, there was functional improvement, decreased edema, and 
decreased reactive astrogliosis. When siCx43 was administered, there was functional 
improvement and decreased reactive astrogliosis, but the level of edema did not change. 
From these findings, it can be seen that (1) AQP4 and Cx43 are upregulated acutely after 
jTBI, (2) both siAQP4 and siCx43 have therapeutic potentials after jTBI leading to 
functional recovery, (3) although both target astrocyte endfeet proteins, the mechanism of 
action seem to be different and AQP4 may play a more direct role in the edema process 
than Cx43. 
Future studies could focus on (1) a more clinically relevant delivery of siRNA for 
jTBI, (2) elucidating the mechanism behind functional improvement of siCx43, and (3) 
the relationship between AQP4 and Cx43 regarding astrocyte pathology after jTBI. 
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CHAPTER ONE 
INTRODUCTION 
 
Clinical Relevance of Juvenile Traumatic 
Brain Injury 
Traumatic brain injury affects at least 1.7 million people in the U.S. directly; and 
this number does not include patients in military, federal, or veterans affair hospitals, or 
people who are not medically treated (Faul et al., 2010). TBI contributes to 30.5% of all 
injury related deaths in the U.S. and causes a huge financial burden. Of especially great 
concern is juvenile traumatic brain injury (jTBI), which is the major cause of death and 
disability in children and adolescents, causing about half a million to get emergency care, 
and the number is still growing (Faul et al., 2010).  jTBI causes long lasting debilities that 
can affect the children’s physical, mental, and emotional ability well into adulthood. 
Despite the damages jTBI cause at the individual, communal, and national level, no 
effective pharmacological treatment exists to date. 
One can say that TBI causes an onset of two stages of injury: primary and 
secondary. Primary injuries are the initial damages resulting from a direct and immediate 
mechanical disruption of the brain tissue and leads to secondary injuries, which are 
indirect and more delayed mechanisms. The severity of primary injuries have been 
decreased in recent years due to increased public and legislative awareness concerning 
preventive measures such as wearing helmets when engaging in a potential TBI causing 
event such as riding bicycles. Thus, research in the development of efficient post-injury 
therapeutic treatments should focus on targeting secondary injuries (Morales et al., 2005). 
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In order to accomplish this, a better understanding of the pathophysiological molecular 
changes that occur in the brain at later time points post injury is needed. This knowledge 
of the long term alterations post-injury is critical in jTBI because the brain is still 
developing, and secondary injuries may have a more severe and long lasting effect in the 
child’s cognitive, emotional, and motor functions than in adult. One such key secondary 
pathological hallmark responsible for the deaths and disabilities after jTBI is cerebral 
edema (Huh and Raghupathi, 2009).  
 
Cerebral Edema 
Edema is an abnormal accumulation of water, whether inside the cell or in the 
extracellular space. Traditionally, cerebral edema has been categorized into two general 
types: cytotoxic and vasogenic (Klatzo, 1967). Cytotoxic edema refers to the cellular 
swelling due to water moving from the extracellular space into the intracellular space 
without disruption of the blood brain barrier (BBB), and vasogenic edema refers to the 
accumulation of water from the blood to the brain parenchyma, due to the disruption of 
the BBB (Papadopoulos and Verkman, 2007). However, recent findings have led some to 
suspect cerebral edema to be a more complicated process with further stages of 
characterization (Simard et al., 2007; Unterberg et al., 2004). One example of this is a 
further categorization of cerebral edema into three stages: anoxic edema, ionic edema, 
and vasogenic edema (Badaut et al., 2011b), taking into consideration the recent 
knowledge on molecular and cellular mechanisms involved in edema formation. Anoxic 
edema occurs within minutes after the cessation of oxygen and energy (such as glucose) 
supplies that result in ionic gradient abnormality, finally causing astrocytic swelling as 
described for cytotoxic edema. In a continuous gradient, the endothelial cells suffer from 
3 
the energy depletion, which contributes to ionic pump dysfunction which results in water 
flow into the brain extracellular space before physical disruption of BBB. This phase is 
called ionic edema that further exacerbates astrocyte swelling and neuronal cell death. 
The final stage termed vasogenic edema occurs because of a massive disruption of BBB 
due to endothelial tight junction destruction, causing leakage of plasma proteins into the 
brain parenchyma, with water following. Regarding TBI, during anoxic and ionic edema, 
cellular swelling and the resultant damage most likely spreads from the initial impact site 
to regions further away, affecting more distant cells due to the characteristic network 
organization of astrocytes, connected by gap junctions. As such, edema most likely 
involves several proteins in the astrocyte, especially those expressed in the perivascular 
astrocyte and astrocyte-astrocyte junctions. Thus, we believe that reducing edema 
formation by targeting these key components of the edema process is an effective 
strategy to facilitate recovery or reduce the secondary damages caused after jTBI.  
 
Aquaporin 4, a Key Astrocyte Water Channel Protein is 
Responsible for Edema Formation 
Aquaporin is a family of water channel protein that is expressed in most 
organisms, including rodents and humans. To date 13 AQPs have been identified in 
mammals, and  3 AQPs in the brain have been characterized so far: AQP1, AQP4, and 
AQP9 (Badaut et al., 2011b). The aquaporin family exhibits a common structure with six 
membrane spanning alpha helical domains, a consensus motif composed of Asparagine-
Proline-Alanine (NPA) constituting part of the pore, and an approximate molecular 
weight of 30 kDa (Gonen and Walz, 2006). AQP4 is the most abundant AQP found in the 
primate and rodent brains, mainly in the perivascular astrocyte endfeet (Badaut et al., 
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2002). AQP4 is assembled in homo-tetramers where each individual aquaporin represents 
a water channel (Yu et al., 2006). The assemblage of four molecules of AQP4 forms a 
central pore, through which water, cations, and gases such as CO2 flow (Musa-Aziz et 
al., 2009). The main function of AQP4 is widely accepted as facilitating water mobility 
(Badaut et al., 2011b), and thus have been studied in relationship with the edema process 
(Fukuda and Badaut, 2012). Recently, this was observed using in vivo inhibition of 
expression of AQP4 with specific siRNA targeting AQP4 (Badaut et al., 2011a),  and 
using diffusion weighted magnetic resonance imaging (DWI), which is widely accepted 
as a measure of water mobility (Badaut et al., 2011a). 
 
Connexin 43, a Key Protein Forming the Astrocyte Network may 
be Responsible for Edema Spread 
In the brain, not only neurons, but also astrocytes form a network in which 
individual astrocytes connect with each other, exchange information, and influence each 
other and the network as a whole. Appropriately, the term astrocyte network (Giaume et 
al., 2010) is frequently used to describe this characteristic. In the network, astrocytes are 
interconnected with each other through gap junctions, which are made of connexin 
proteins: predominantly connexin 43 (Cx43), but also connexin 30 (Cx30), that facilitate 
intercellular communication, and possibly intracellular communication (Wolff et al., 
1998). The connexin subtypes are named according to their molecular weight, thus Cx43 
has a molecular weight of 43kDa and Cx30 has that of 30kDa. Six connexin proteins 
form a connexon, which is a hemichannel, and when a hemichannel from one cell is 
aligned with another hemichannel of an adjacent cell, that is called a gap junction. 
Therefore, 12 connexins make up one gap junction. Of these connexins, Cx43, which is 
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predominantly astrocytic (Giaume et al., 2010; Rash et al., 2001), is one of the most 
studied connexin in the brain and highly expressed because astrocytes far outnumber 
other cell types in the brain, including neurons (Sofroniew and Vinters, 2010). Connexin 
43 form a hemichannel, which form a gap junction, which has an aqueous pore and 
selectively permits flow of small endogenous molecules such as second messengers, 
amino acids, nucleotides, small peptides, and also water intercellularly between 
astrocytes (Giaume et al., 2010; Goodenough and Paul, 2003; Herve and Derangeon, 
2012; Wallraff et al., 2006). Although various cell types such as neurons, 
oligodendrocytes, and endothelial cells swell after injury, astrocytes are the first cell 
types to swell, and the swelling lasts the longest; in fact, perivascular astrocyte endfeet 
can swell within minutes after injury (Grange-Messent and Bouchaud, 1994), and this 
swelling may spread from primary injury site to distant sites because of the astrocyte 
network mediated by gap junctions. This hypothesized spread of detrimental factors from 
the primary injury site to more distant sites mediated by gap junctions is often referred to 
as “bystander effect” (Andrade-Rozental et al., 2000; Cronin et al., 2008; Perez 
Velazquez et al., 2003). Thus, the inhibition of connexin 43 will decrease this bystander 
effect and lead to better recovery after jTBI. Accordingly, several studies have shown 
that administering gap junction inhibitors such as carbenoxolone and octanol after brain 
pathology resulted in beneficial outcome (Andersson et al., 2011; Frantseva et al., 2002; 
Perez Velazquez et al., 2006; Rawanduzy et al., 1997) . However, gap junction inhibitors 
are not specific for individual connexins or particular cell types and have side effects, 
thus unable to pinpoint the function of each connexins in a definitive manner, and 
difficult to transition as a clinical therapeutic (Goodenough and Paul, 2003). Furthermore, 
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recent studies have shown that non gap junction forming hemichannels may have specific 
functions as well such as extracellular signaling of ATP and glutamate under 
physiological and pathological conditions (Kar et al., 2012). Therefore, the usage of 
specific connexin inhibitors will be of paramount importance not only in learning about 
the physiological functions under normal and pathological conditions, but also as 
potential therapeutics. 
 
T2 Weighted Imaging and Diffusion Weighted Imaging in the 
Assessment of Edema 
Clinically, Diffusion Weighted Imaging (DWI) alongside the standard T2 
weighted imaging (T2WI) is used widely as a diagnostic tool in clinical and research 
settings; among them to assess edematous damage after various brain pathologies from 
ischemic stroke to TBI (Chastain et al., 2009; Obenaus and Ashwal, 2008; Tourdias et al., 
2009; Tourdias et al., 2011). The computed T2 value is believed to represent the water 
content within brain tissues; where increased T2 values correspond to water accumulation 
in pathological conditions (Obenaus and Ashwal, 2008). 
DWI makes use of the characteristic property of water motion when excited by 
magnetic field gradients, and the rate of diffusion of water can be assessed (Bydder et al., 
2001). The rate of diffusion of water is most often interpreted in a value termed the 
apparent diffusion coefficient (ADC). The first published data for DWI usage in the 
pediatric population was published in 1991 (Rutherford et al., 1991; Sakuma et al., 1991) 
and is now quite routinely used in pediatric neuropathologies including jTBI (Badaut et 
al., 2007; Galloway et al., 2008; Hou et al., 2007; Utsunomiya, 2011). In animal studies, 
DWI has also started to gain popularity (Badaut et al., 2007; Badaut et al., 2011a; 
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Bertolizio et al., 2011; Obenaus and Ashwal, 2008; Wang et al., 2007), although there are 
many more studies done in adults than juvenile animals. Because there are differences in 
brain structure and physiology between the pediatric population and adult population 
such as higher water content in pediatric brain, adult TBI studies should not be directly 
translated into the pediatric population without careful research and clinical evidence. 
Despite the usage of DWI, the exact molecular mechanisms that contribute to 
ADC differences are still unknown. But we hypothesize that aquaporin 4 (AQP4), which 
has been proposed as a key player in the cerebral edema process in several brain 
disorders including TBI, contributes to ADC values. Because DWI detects changes 
observed via the excitation of protons, and water molecules are the main source of 
protons being detected in the brain, the presence of the water channel protein, AQP4, in 
astrocytes suggests a possible involvement. A decrease in the ADC is classically 
associated with a decrease in the extracellular space during cellular swelling after brain 
injury (Obenaus and Ashwal, 2008). More recently, ADC changes have been 
hypothesized to be linked with the level of expression of AQP4. Several experiments 
have shown increases in AQP4 expression and increased ADC (Tourdias et al., 2009) and 
decreased AQP4 expression with decreased ADC (Badaut et al., 2011a; Meng et al., 
2004). Of note, Tourdias et al. (Tourdias et al., 2011) have shown in a model of acute 
brain pathology that AQP4 upregulation was associated with early edema formation via 
increased ADC and BBB disruption. With our hypothesized role of Cx43 in edema 
spread, we also propose that Cx43, in conjunction with AQP4 will affect ADC values. 
 
 
8 
Evidences Linking AQP4 and Cx43 
So far, we have covered how AQP4 and Cx43 can play major roles in the edema 
process after jTBI independently. However, in order to maintain homeostasis, astrocyte 
proteins have to work in an intricate concerted manner. Is there a possibility that AQP4 
and Cx43 have regulatory functions on each other? Interestingly, a decrease in Cx43 
protein expression and a concomitant decrease in gap junction function after 
administration of siRNA against AQP4 in primary astrocyte culture have been reported 
(Nicchia et al., 2005). Additionally, brain cell cultures taken from AQP4 -/- mice have 
also shown lower Cx43 protein level compared to wildtype (Kong et al., 2008). And also, 
transgenic mice lacking Cx43 and Cx30 have decreased AQP4 levels (Ezan et al., 2012).  
 
Small Interference RNA as a Research and Therapeutic Tool to 
Downregulate AQP4 and Cx43 
In order to test our hypothesis that AQP4 and Cx43 played key regulatory roles in the 
post traumatic edema process, we needed to find a tool to specifically downregulate these 
astrocyte proteins post-injury. A recently discovered tool that fit this criterion was the 
small interference RNA molecules.  
Small interference RNA (siRNA) is a short double-stranded molecule composed of 
about 20 nucleotide base pairs organized in corresponding sense and antisense strands. 
These short double-stranded molecules are produced as a result of an enzyme called 
Dicer (Bernstein et al., 2001; Ketting et al., 2001), which cleaves a longer double-
stranded RNA present in the cell cytoplasm. These double-stranded RNA composed of 
both the sense and antisense strand is a necessary trigger for the generation of siRNA. 
This was elegantly demonstrated by Mello and Fire, when phenotypic changes were 
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observed in C. elegans following insertion of both the sense and antisense mRNA of a 
particular protein, but no changes occurred upon delivery of a single strand of either the 
sense or antisense strand (Fire et al., 1998; Montgomery et al., 1998). Once siRNA is 
made, it enters a protein complex called the RNA induced silencing complex (RISC) 
where Argonaut 2 cleaves the sense strand away from the antisense strand. The antisense 
strand remaining within RISC is now free to target complementary endogenous mRNA 
for subsequent cleavage by the RISC-Argonaut2-siRNA complex, thereby interfering 
with the translation process of that specific protein (Ketting et al., 2001). This ultimately 
leads to significant down-regulation of the protein normally encoded by the targeted 
mRNA (Figure 1).  
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Figure 1. Basic molecular mechanism of siRNA. 1) The enzyme, dicer, cleaves a double 
stranded RNA in the cell cytoplasm. 2) This cleavage forms a shorter double-stranded 
RNA composed of both the sense and antisense strand. 3) Once siRNA is made, it enters 
a protein complex called the RNA induced silencing complex (RISC) where 4) Argonaut 
2 cleaves the sense strand away from the antisense strand. 5) The antisense strand 
remaining within RISC is now free to target complementary endogenous mRNA for 
subsequent cleavage by the RISC-Argonaut2-siRNA complex, 6) thereby interfering with 
the translation process of that specific protein.  
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This elegant yet simple mechanism allowed the advent of numerous basic science 
discoveries and research advances due to the specificity and potency of the RNA 
interference mechanism in targeting proteins of interests. Ongoing research interests 
include translational approaches of this newfound mechanism into clinical practice, and using 
siRNA as a therapeutic agent against diseases including acute brain injuries (Fukuda and 
Badaut, 2013). 
Small interfering RNA (siRNA) transfection offers a new exciting therapeutic 
possibility for brain disorders, through specific inhibition of translation of one targeted 
protein. siAQP4 injection in non-injured rat brains resulted in a significant decrease of 
water movement evaluated with magnetic resonance imaging (MRI) and the apparent 
diffusion coefficient (ADC) values (Badaut et al., 2011a). Importantly, in vivo siAQP4 
injection did not produce adverse side effects or mortalities compared to naïve animals, 
suggesting the safety of this method for early inhibition of AQP4 expression after brain 
injury (Badaut et al., 2011a). Small interference RNA targeting AQP4 (siAQP4) and 
Cx43 (siCx43) are expected to decrease edema formation and improve outcomes after 
jTBI. Thus, the dissertation research’s unique purpose is to determine the contribution of 
the astrocyte network in jTBI pathophysiology. 
Previous experiments have shown that siAQP4 injection in non-injured juvenile 
rat brains induced a 50% decrease in water mobility as interpreted from MRI ADC 
values, along with a 30% reduction in AQP4 protein expression (Badaut et al., 2011a). 
These discrepancies between the two percentage values suggest the possible involvement 
of additional molecular players such as Cx43 as proposed above. 
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Summary 
In summary, jTBI is a serious health concern with no therapeutic treatment 
available. Edema, which can be visualized by the usage of DWI, is an effective target to 
ameliorate secondary damage caused by jTBI, facilitating improved recovery. In order to 
accomplish this, the inhibition of the gap junction protein, Cx43, and the perivascular 
astrocyte endfeet water channel protein, AQP4, will be very effective.  
 
Study Objectives 
Using AQP4 and Cx43 as siRNA targets provides a unique platform to study the 
role of the astrocyte network in water diffusion contributing to edema formation after 
juvenile traumatic brain injury.  
We will have three different aims split up into three chapters (Ch. 2-4) to answer 
our question proposed above. Aim 1 (Ch. 2) will characterize the expression of the 
aquaporins after our juvenile traumatic brain injury (jTBI) model, correlating these 
protein levels with edema. Aim 2 (Ch. 3) will explore novel therapeutic administration of 
siAQP4 in vivo after jTBI with measures on edema formation via MRI, behavior 
outcome, AQP4 expressions and histology of the neurovascular unit. Aim 3 (Ch. 4) is to 
characterize the expression of the connexins after our juvenile traumatic brain injury 
(jTBI) model and explore novel therapeutic administration of siCx43 in vivo after jTBI 
with measures on edema formation via MRI, behavior outcome, and Cx and GFAP 
expressions.   
Together, these novel studies will provide new information and knowledge on 
astrocyte pathophysiology and contribute to the development of new therapeutic 
approaches for jTBI and other brain injuries associated with the edema process. 
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Key Novelties of the Studies 
Characterization of Aquaporin and 
Connexin after jTBI 
 
Our study will be looking at the changes in the expression pattern of water 
channels and gap junctions after jTBI. Characterization of these proteins has not been 
performed in models of jTBI. We will be looking at the spatial and temporal changes of 
these proteins along the process of edema formation and resolution. Of particular 
importance to our astrocyte network hypothesis, the key astrocyte aquaporin-AQP4 and 
connexin-Cx43 will be our central focus in our characterization.  
 
Usage of siRNA against AQP4 or Cx43  
In Vivo in the Brain after jTBI 
 
Small interference RNA has been gaining considerable attention and is used as 
both a molecular tool and a potential therapeutic agent. However, very few studies use 
siRNA in vivo in the brain under pathological and non-pathological conditions. This 
study will be the first to use siAQP4 and siCx43 in vivo after jTBI as a therapeutic agent. 
 
Astrocyte Network as a Target to Decrease Edema 
We will be the first to target key proteins of the astrocyte network as therapeutic 
targets after jTBI. Little is known regarding the changes in astrocyte fates after brain 
injuries and the contribution of the astrocyte network in edema formation and resolution. 
We hypothesize that the inhibition of AQP4 or Cx43 will result in edema decrease and 
better behavioral recovery after jTBI. 
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Abstract 
 
Traumatic brain injury (TBI) is one of the leading causes of death and disability in 
children and adolescents. The neuropathological sequelae that result from TBI are a 
complex cascade of events including edema formation, which occurs more frequently in 
the pediatric than the adult population. This developmental difference in the response to 
injury may be related to higher water content in the young brain and also to molecular 
mechanisms regulating water homeostasis. Aquaporins (AQPs) provide a unique 
opportunity to examine the mechanisms underlying water mobility, which remain poorly 
understood in the juvenile post-traumatic edema process. We examined the 
spatiotemporal expression pattern of principal brain AQPs (AQP1, 4, and 9) after juvenile 
TBI (jTBI) related to edema formation and resolution observed using magnetic resonance 
imaging (MRI).  
Using a controlled cortical impact in post-natal 17 day-old rats as a model of 
jTBI, neuroimaging analysis showed a global decrease in water mobility (apparent 
diffusion coefficient, ADC) and an increase in edema (T2-values) at 1 day post-injury, 
which normalized by 3 days. Immunohistochemical analysis of AQP4 in perivascular 
astrocyte endfeet was increased in the lesion at 3 and 7 days post-injury as edema 
resolved. In contrast, AQP1 levels distant from the injury site were increased at 7, 30, and 
60 days within septal neurons but did not correlate with changes in edema formation. 
Group differences were not observed for AQP9. Overall, our observations confirm that 
astrocytic AQP4 plays a more central role than AQP1 or AQP9 during the edema process 
in the young brain. 
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Introduction 
Traumatic brain injury (TBI) has been termed a ‘silent epidemic’ in the United States 
in recent years because of its increased medical and financial burden. TBI affects about 
1.7 million people annually and contributes to 30.5% of all injury-related deaths in the 
U.S. An important subgroup of this population are children and adolescents ranging in 
age from 0-14 years, of which half a million visit emergency departments for TBI (Faul 
M, 2010). Juvenile TBI (jTBI) is the primary cause of death and disability in children and 
adolescents (Schneier et al., 2006) with long-term impairments in motor and cognitive 
abilities, including deficits in intellectual functioning, attention, memory, language, 
sensorimotor, visual-spatial, and executive skills (Adelson and Kochanek, 1998, Adelson 
et al., 1998). Despite increases in prevalence and resulting catastrophic effects of jTBI, 
there are no effective pharmacological treatments. 
TBI in infants and children is more frequently associated with severe brain swelling 
than in adults (Lang et al., 1994, Bauer and Fritz, 2004) that may affect the edema 
process. Two mechanisms may account for these age-related differences: (i) increased 
post-injury cerebral blood flow in the young, and (ii) developmental and mechanical 
properties of the brain and skull (Kochanek, 2006). Experimental studies suggest that 
post-traumatic edema in the immature brain may also be related to enhanced diffusion of 
excitotoxic neurotransmitters, an intensified inflammatory response (Kochanek, 2006), 
and higher brain water content in the young rat compared to the adult rat (Dobbing and 
Sands, 1981).  
Developmental differences in water homeostasis between children and adults may 
also account for the observed greater risk of post-traumatic edema in the younger 
population. Aquaporins (AQPs), a family of water channel proteins, are recognized to 
23 
have an important role in brain water regulation (Badaut et al., 2011b). In rodents and 
humans, AQP4 and AQP1 show increased expression during brain development (Wen et 
al., 1999, Gomori et al., 2006, Hsu et al., 2011). To date, three different AQPs (AQP1, 
AQP4, and AQP9) have been identified in vivo in the brain and each are hypothesized to 
play different roles during normal physiological and neuropathological states (Badaut et 
al., 2007).  For example, AQP1 in epithelial cells of the choroid plexus appears to 
contribute primarily to cerebrospinal fluid formation whereas the neuronal AQP1 may 
play a role in pain processing (Oshio et al., 2006).  AQP9 in astrocytes and 
catecholaminergic neurons may contribute to the regulation of brain energy metabolism 
(Badaut, 2010).  In contrast, AQP4 appears to have multiple roles including: (i) water 
homeostasis and edema formation (Papadopoulos et al., 2004, Badaut et al., 2011a, 
Badaut et al., 2011b, Lee et al., 2011); (ii) regulation of synaptic plasticity with 
regulation of p75NTR (Skucas et al., 2011); and (iii) modulation of neurogenesis (Zheng 
et al., 2010).  
The intricate role of brain AQPs after injury may depend on underlying pathology 
and type of edema (Badaut et al., 2011b), and AQP findings in several TBI studies using 
adult rodents have provided conflicting results. In some reports, AQP4 expression is 
increased (Sun et al., 2003, Guo et al., 2006, Ding et al., 2009, Higashida et al., 2011, 
Tomura et al., 2011) whereas other investigators have reported decreased expression (Ke 
et al., 2001, Kiening et al., 2002, Zhao et al., 2005).  Interestingly, more recent studies 
have shown both AQP1 (Tran et al., 2010, Oliva et al., 2011) and AQP9 (Ding et al., 
2009, Oliva et al., 2011) increasing after injury. Notably, these previous studies were 
undertaken in adult rats and the majority only examined AQP4 expression for up to 48 
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hours, without correlations of AQP levels with edema formation and resolution via 
neuroimaging. In other injury models, AQP expression is observed acutely and in the 
long-term, such as in spinal cord injury where AQP1 (Nesic et al., 2008) and AQP4 
(Nesic et al., 2010) are increased 5 and 11 months after injury. 
Developmental differences in water homeostasis and AQP expression between 
children and adults raises the question whether AQPs play a critical role in regulating 
brain water content in the developing brain after TBI.  To address this question, we 
examined edema formation and resolution using magnetic resonance imaging (MRI) in 
conjunction with protein levels of AQP1, 4, and 9 by immunohistochemistry and western 
blot in a model of jTBI. 
 
Material and Methods 
Animals 
All protocols and procedures were in compliance with the U.S. Department of 
Health and Human Services Guide and were approved by the Institutional Animal Care 
and Use Committee of Loma Linda University. Briefly, juvenile male Sprague-Dawley 
rats (P10, Harlan, Indianapolis, IN) were housed with their dams on a 12-hour light-dark 
cycle schedule, at constant temperature and humidity, for seven days prior to surgery at 
P17. Upon weaning at seven days after surgery, the rats were housed two per cage. 
Animals were fed with standard lab chow and water ad libitum.  
 
Juvenile Traumatic Brain Injury Model 
Controlled cortical impact (CCI) was induced in 17 day old rat pups as previously 
described (Ajao et al., in press). Briefly, P17 juvenile rats were anesthetized with 
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isoflurane (Webster Veterinary Supply, Inc., Sterling, MA) and placed into a stereotaxic 
frame (David Kopf Instruments, USA). Following a midline skin incision over the skull, 
a 5mm craniotomy was performed over the right frontal-parietal cortex (Bregma: -1mm 
anterior-posterior and 2mm medial-lateral). CCI was induced in the jTBI group using a 
3mm rounded-tip metal impactor fixed to an electromechanical actuator and centered 
over the exposed dura at a 20° angle to the cortical surface (Leica Microsystems 
Company, Richmond, IL). The CCI was delivered at a 1.5 mm depth with impact 
duration of 200 ms at a velocity of 6 m/s. The surgical site was sutured after recording 
any bleeding or herniation of cortical tissues (Ajao et al., in press). After the craniotomy, 
the dura was intact in all of the animals in both groups (sham and jTBI). After induction 
of jTBI none of the animals had bleeding and all of the animals had a similar minimal 
damage on the dura. Body temperature was maintained at 37°C during surgery. 
Following surgery, animals received one subcutaneous injection of buprenorphine 
(0.01mg/kg; dilution: 0.01mg/ml) for pain relief before the animals were returned to their 
cages. 
 
Magnetic Resonance Imaging and Analysis 
Magnetic Resonance Imaging (MRI) was performed at 1, 3, 7, and 30 days post-
injury (d). Rats were lightly anesthetized using isoflurane (1.0%) and then imaged on a 
Bruker Avance 11.7 T MRI (Bruker Biospin, Billerica MA, 8.9 cm bore) for the 1, 3, and 
7d timepoints, or on a larger bore (40 cm) 4.7T MRI (Bruker Biospin, Billerca, MA) for 
the 30d scan, based on the size of the animals (Badaut et al., 2011a; Ajao et al., in press). 
Two imaging data sets were acquired: 1) a 10 echo T2 weighted imaging (T2WI), and 2) 
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a diffusion weighted imaging (DWI) sequence where each sequence collected twenty 
coronal slices (1 mm thickness and interleaved by 1 mm). The T2 sequence had the 
following parameters:  TR/TE = 4600 ms/10.2 ms, matrix = 128 X 128, field of view 
(FOV) = 3 cm, NEX = 2 and acquisition time = 20 min. The spin echo diffusion sequence 
parameters were TR/TE = 3000 ms/25 ms, b-values = 0.72, 1855.64 s/mm
2
, matrix = 128 
X 128, FOV = 3 cm, NEX = 2 and acquisition time = 25 min. 
Spin-spin relaxation time (T2) and apparent diffusion coefficient (ADC) values 
were quantified using standardized protocols (Badaut et al., 2007). T2 relaxation rates 
were determined for each pixel and T2 maps generated. ADC maps were calculated using 
a linear two point fit. Four primary regions of interest (ROIs) within ipsi- and 
contralateral hemispheres (cortex and striatum) were delineated on T2WI. These ROIs 
were overlaid onto corresponding T2 and ADC maps and the mean, standard deviation, 
number of pixels, and area for each ROI were extracted. MRI analysis was performed 
blinded without knowledge of experimental group. Data were represented as percentage 
of sham values to facilitate comparison to AQP changes. 
 
Tissue Processing 
Rats were transcardially perfused with 4% paraformaldehyde (PFA) prepared in 
phosphate buffered saline (PBS) at 1, 3, 7, 30, and 60 d. Brains were immersed in 30% 
sucrose at 4
o
C for 48 hours and then frozen on dry ice and stored at -20
o
C (Badaut et al., 
2004). Free-floating coronal sections were cut on a cryostat (Leica CM1850, Leica 
Microsystems GmbH, Wetzlar, Germany) at 15µm thickness for 1, 3, 7, and 30 d tissue, 
and at 50µm thickness for 60d tissue. 
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Immunohistochemistry 
All antibody incubations were carried out in PBS (Fisher Scientific, Pittsburgh, 
PA) containing 0.25% Triton X-100 and 0.25% bovine serum albumin (BSA) (both from 
Sigma-Aldrich Co., St. Louis, MO). Briefly, after washes in PBS, sections were pre-
incubated for 90 minutes in PBS with 1% BSA, and then incubated overnight at 4°C with 
the various primary antibodies and their respective dilutions as described in Table 1. 
After rinsing, sections were incubated for 90 minutes at room temperature with the 
secondary antibodies (Table 1). After subsequent washes in PBS for 3x10min, sections 
on glass slides were cover-slipped with anti-fading medium VectaShield containing 
DAPI (Vector, Vector laboratories, Burlingame, CA). Negative control staining where 
the primary antibody was omitted showed no detectable labelling, and depletion of the 
AQP4 antibody by an excess of the specific peptide (Chemicon International, Temecula, 
CA) was also carried out and gave negative results as previously observed (Ribeiro Mde 
et al., 2006). 
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Table 1. Antibodies and dilutions used in this study. 
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Immunohistochemistry Analysis 
 Intensity of the AQP4 immunoreactivity was quantified using the LI-COR-
Odyssey analysis software as previously described (Badaut et al., 2011a). Briefly, the 
level of fluorescence was quantified in ROIs similar to that of MRI analysis: ipsilateral 
hemisphere (lesion and perilesion) and contralateral hemisphere (cortex and striatum). 
Values obtained for the jTBI were also normalized to the sham values of the 
corresponding ROIs. 
Non-infrared stained tissues were observed under an epifluorescent light 
microscope (Olympus, BX41, Center Valley, PA USA) and pictures were obtained using 
Fluo-Up (Explora-Nova, La Rochelle, France) and confocal microscope (Zeiss). AQP1 
and 4 immunostaining were scored using a relative scale including a combination of the 
intensity and pattern of staining.  AQP1 was scored in the following brain structures: 
choroid plexus, ependymal cells of the lateral and third ventricle, and lateral septal 
nucleus (n=5-8 animals/region/timepoint). Scoring was given a value from 0-4 with (0) 
no staining seen; (1) faint staining in a few positive cells, (2) bright staining in a small 
area, or low intensity staining in a larger area (more positive cells), (3) bright staining in a 
larger area, or (4) very intense staining over a large area. AQP4 staining was scored on 
the tissue collected at 60d with a scale representing the distribution patterns of the protein 
on astrocyte endfeet along brain vessels in the ipsilateral and contralateral sides of the 
lesion at multiple coronal bregma levels, from 4.2mm to -5.2mm throughout the 
longitudinal brain axis (demonstrated in Figure 5). The regions scored for AQP4 were: 
dorsal frontal-parietal cortex and lateral parietal temporal cortex in the sham and jTBI 
(n=5-8 animals/region). The AQP4 scale was from 0-4 with (0) no perivascular staining, 
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(1) few scattered areas of perivascular staining at moderate brightness, (2) many areas of 
perivascular staining at moderate brightness, (3) several high density areas of 
perivascular staining at moderate brightness (4) entire region has extensive and very 
bright staining of AQP4 on perivascular astrocyte endfeet. No analysed regions received 
a score of 0, and category 4 was most often observed in anterior sections far from the 
injury site. 
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Figure 5. Aquaporin 4 Western Blot Analysis Sham vs jTBI. (A) Western blot of AQP4 
at 7d shows two distinct bands of AQP4 at around 30kDa, corresponding to the M1 and 
M23 isoforms of AQP4. (B) jTBI shows a significantly higher expression of both M1 and 
M23 compared to sham. AQP4-M23 was significantly higher than the M1 in sham. 
(AQP4, aquaporin 4; kDa, kilo Dalton; jTBI, juvenile traumatic brain injury; *p<0.05, 
**p<0.01). 
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AQP4 Western Blot Analysis 
After magnetic resonance imaging at 7d, brains from 3 animals per group were 
freshly dissected with collection of cortex adjacent to the site of the impact. Tissues were 
prepared in RIPA buffer with protease inhibitor cocktail  (PIC, Roche, Basel, 
Switzerland) and sonicated for 30 seconds. One μg of protein was then subjected to SDS 
polyacrylamide gel electrophoresis on a 4-12% gel (Nupage, Invitrogen, Carlsbad, CA). 
Proteins were then transferred to a polyvinylidene fluoride membrane (PerkinElmer, 
Germany). The blot was incubated with a polyclonal antibody against AQP4 (Millipore, 
California, 1:2000) and a monoclonal antibody against tubulin (Sigma, Switzerland, 
1:25,000) in Odyssey blocking buffer (LI-COR, Bioscience, Germany) for 2 hrs at room 
temperature. After washing in PBS, the filter was incubated with two fluorescence-
coupled secondary antibodies (1:10,000, anti-rabbit Alexa-Fluor-680nm, Molecular 
Probes, Oregon and anti-mouse infra-red-Dye-800-nm, Roche, Germany) for 2 hours at 
room temperature. After washing in PBS, the degree of fluorescence was measured using 
an infra-red scanner (Odyssey, LI-COR, Germany). 
 
Statistical Analysis 
For MRI, infrared ROI, and western blot analysis, a student’s t-test was 
performed between groups. Categorical data were assessed using a non-parametric Mann-
Whitney U (M-W) test to assess group differences. 
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Results 
Apparent Diffusion Coefficient (ADC)  
and T2 Values 
 
To address the time course of edema following TBI in our juvenile rat model, 
ADC and T2 values were analysed in the ipsilateral cortex including the lesion and the 
perilesion regions. Analysis was also performed distant from the injury site, for the 
contralateral cortex, ipsilateral striatum and contralateral striatum (Fig. 1). ADC and T2 
values were reported relative to sham values. At 1d, ADC was significantly decreased 
within the lesion (39.5 ± 2.4%) and perilesion (45.0 ± 2.7%) regions compared to shams. 
A significant decrease in ADC values was also observed in the contralateral cortex (41.1 
± 9.4%) and striatum (41.3 ± 9.4%) (Fig 1A, B, C). ADC values normalized at 3 and 7d 
in all regions (Figure 1A, B, C). However, ADC became significantly elevated in the 
jTBI animals at 30 d within the lesion. 
Parallel to the ADC changes, T2 values were significantly higher in the jTBI 
animals compared to shams at 1d (44.4 ± 3.3% increase in the lesion, 47.5 ± 6.9% in the 
perilesion, 46.1 ± 1.6% in contralateral cortex and 46.3 ± 3.5% in the striatum). Edema 
remained elevated at 3d for all the regions assessed but returned to sham values at 7 and 
30d  (Figure 1 D, E, F).  
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Figure 1. Changes in T2 and ADC in Sham vs jTBI. (A) DWI at 24hours after jTBI 
shows an increase in the size of the lesion and the perilesion compared to the sham group 
(B, C) Relative changes of the ADC values in the lesion and perilesion regions (B) and 
contralateral cortex (contra-cx) and contra-striatum show a decrease in the ADC values in 
all ROIs at 1d then increase at 30d in the lesion (*p<0.01). (D) T2 weighted images (T2) 
at 24h after jTBI show the increase of T2 signal in different brain regions compared to 
the sham. (E, F) Relative changes of the T2 values in the lesion and perilesion (B) and 
contralateral cortex (contra-cx) and contra-striatum show an increase of the T2 values in 
all ROIs at 1and 3d before to be normalized in all ROIs. (DWI, diffusion weighted 
images; jTBI, juvenile traumatic brain injury; ADC, apparent diffusion coefficient; ROI, 
region of interest; d, days post injury;  *p<0.01). 
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Increase of AQP1 Expression in 
Neurons after jTBI 
 To address the contribution of AQPs following jTBI, we first evaluated AQP1 
levels by immunohistochemistry. AQP1 staining was predominantly observed in the 
apical membrane of the choroid plexus at similar levels between jTBI and sham groups 
(Figure 2 A and B). The absence of differences between groups may be due to the 
relatively large distance between the choroid plexus and the site of the impact, which is 
approximately 2mm.  
 A few AQP1 positive neurons were observed in the ipsilateral and contralateral 
parietal cortex in sham and jTBI rat pups at each time point as reported previously 
(Ribeiro Mde et al., 2006). No overt differences of the AQP1 staining were observed in 
the cortical and striatal regions where ADC and T2 values were changed. However, a 
striking increase in AQP1 staining was observed in jTBI rat pups after 7d, specifically in 
the neuronal dendrites in the dorso-lateral septal nucleus, just below the medial corpus 
callosum (Figure 2C-E). While quantification based on the intensity and pattern of the 
AQP1 staining at 1 and 3 d showed no significant differences, jTBI animals exhibited a 
significant increase at 7, 30, and 60 d (p<0.001) with greater staining intensity on several 
neuronal processes compared to sham (Figure 2). The changes in AQP1 expression 
starting at 7d strongly suggested that the changes in neuronal AQP1 expression may not 
be directly related to edema formation and resolution as observed in MRI.  
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 Figure 2. Aquaporin 1 Changes Sham vs jTBI. (A) AQP1 staining in the choroid plexus 
of sham and (B) jTBI shows no difference in intensity or pattern of staining. (C) AQP1 
staining in the dorso-lateral septal nucleus of sham compared to that of (D) jTBI shows a 
(E) significant increase in staining in the jTBI animals at 7d, 28d, and 60d.  
(AQP1, aquaporin1; jTBI, juvenile traumatic brain injury; DLSN, dorsal lateral sepal 
nucleus; d, days post injury; scale bar = 100 μm, *p<0.01). 
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AQP4 Expression in Astrocytes 
We determined the evolution of AQP4 immunoreactivity (IR) using infra-red 
labelling over several post-injury timepoints and compared our results with MRI 
detection. Our data indicate several changes over time in the areas ipsilateral to the lesion 
(Figure 3) and on the contralateral side (Figure 4). Quantification of AQP4-IR using 
infra-red labeling (Figure 3C, 4C) was confirmed at higher magnification with classical 
immunostaining (Figure 3B, 4B).  The intensity of the AQP4-IR using infra-red labelling 
was not significantly changed within the ipsilateral lesion and perilesional cortex between 
jTBI and sham animals at 1d (Figure 3). However, AQP4-IR was significantly decreased 
in the contralateral striatum in jTBI compared to sham animals, but not in the 
contralateral cortex at 1d (Figure 4). When ADC values and T2 values normalized 
(Figure 1), AQP4-IR significantly increased within the lesion at 3 and 7d (Figure 3). No 
differences were observed in AQP4 staining at 3 and 7 d in the contralateral cortex or 
striatum (Figure 4). AQP4-IR normalized at 30 d in all regions (Figure 3C, 4C).  
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Figure 3. Aquaporin 4 Changes Ipsilateral Sham vs jTBI. (A) DWI, (A left) and AQP4 
immunoreactivity (A, right) at 7d after jTBI show the location of the lesion and perilesion 
ROIs used for the analysis and the location of the pictures, B2 and B4 in the red boxes. 
(B1, B2, B3, B4) AQP4 (red) and GFAP (green) staining in the lesion area of the 
ipsilateral cortex near the surface in cortical layers I-II (B1, B2) and at the layer V (B3, 
B4) shows an increase of the AQP4 staining intensity at the glia limitans of jTBI (B2) 
compared to the shams (B1) and in the intracortical astrocytes in jTBI (B4) compared to 
sham (B3). (Scale bar = 100 μm.). (C) AQP4 staining quantification was performed in the 
ROIs (lesion, perilesion, contralaral cortex and striatum, see figure 4). AQP4 
immunoreactivity shows a significant increase of the in the lesion and perilesion at 3 and 
7d (*p<0.05). (DWI, diffusion weighted imaging; AQP4, aquaporin 4; d, days post 
injury; jTBI, juvenile traumatic brain injury; ROIs, regions of interest; GFAP, glial 
fibrillary acidic protein). 
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Figure 4. Aquaporin 4 Changes Contralateral Sham vs jTBI. (A) DWI (left) and AQP4 
immunoreactivity (right) at 1d after jTBI show the location of the contralateral cortex and 
striatum ROIs used for the analysis as well as the location of the pictures B2 and B4 in 
the red boxes. (B1, B2, B3, B4) AQP4 (red) and GFAP (green) staining in the contra-
cortex (B1, B2) and contra-striatum (B3, B4) show a decrease of the perivascular AQP4 
staining in contra-cortex and contra-striatum of jTBI rats (B2, B4) compared to sham 
(B1, B3). Scale bar = 100 μm. (C) AQP4 staining quantification shows a significant 
decrease of the AQP4 staining in the contra-striatum at 1d (*p<0.05). (DWI, diffusion 
weighted imaging; AQP4, aquaporin 4; d, days post injury; jTBI, juvenile traumatic brain 
injury; ROIs, regions of interest; GFAP, glial fibrillary acidic protein). 
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More specifically, the higher magnification images show decreased AQP4 
labeling on the astrocyte endfeet in contact with blood vessels in the contralateral 
striatum of jTBI compared to the sham rats at 1d (Figure 4B). At 3 and 7d, the increased 
AQP4 IR was not only on astrocyte endfeet but also on astrocyte processes and in the glia 
limitans (Figure 3B). The increase in immunoreactivity of AQP4-IR at 7 d was confirmed 
by western blot (Figure 5). We observed a significant increase in both isoforms of AQP4 
(M23, M1) in jTBI compared to sham animals (Figure 5A). While the ratio of M23 to M1 
did not differ between groups, the level of M23 expression was significantly higher than 
M1 expression in both sham and jTBI animals (Figure 5B). 
At 60d, infra-red analysis showed no overall differences between groups; 
however, at higher magnification, AQP4 immunoreactivity revealed differences in the 
pattern of the staining (Figure 6). The density and distribution of AQP4 staining was 
categorized as Types 0-4 (see Methods and Figure 6C-F). Specifically, jTBI animals 
exhibited a scattered pattern of AQP4 immunostaining on the perivascular astrocyte 
endfeet in the dorsal parietal cortex region surrounding the lesion cavity at bregma -0.4, -
1.4, -2.6 (p<0.05) (Figure 6G) at 60d. No changes were observed between sham and jTBI 
groups in the dorsal frontal cortex region at more anterior bregma levels (data not 
shown). Notably, the areas of reduced AQP4-staining correspond to the coronal slices 
with a visible lesion cavity at 60d. As expected, high AQP4-IR was observed in the glial 
scar immediately surrounding the lesional cavity in jTBI animals at 60d (Figure 6B). 
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Figure 6. Aquaporin 4 60 days Sham vs jTBI. (A) A mosaic 10X image of representative 
Sham with AQP4 in perilesional cortex near Bregma level -2.6mm. (B) A mosaic 10X 
image of representative Sham with AQP4 in perilesional cortex near Bregma level -
2.6mm. (bars in A, B= 500 μm) (C-F) Representative images from the parietal cortex 
showing four immunostaining patterns on astrocyte endfeet resting on micro- and macro-
vessels. AQP4 was scored according to positive perivascular staining patterns as either 
Type 1, Type 2, Type 3, or Type 4. (bars in C-F = 100 μm) (G) Approximated drawing of 
the lesion size and location in jTBI animals at 60d (black ovals) located in the 
somatosensory cortex and spans a few coronal levels. Categorical AQP4 scores were 
assigned to the outlined area at each of the 6 coronal levels depicted. Different staining 
pattern of AQP4 protein expression was found in the ipsilateral dorsal cortex of jTBI 
nearest to the lesion cavity at Bregma -0.4mm, -1.4mm, -2.6mm, and a trend of smaller 
decrease more posteriorly at -3.8mm. (AQP4, aquaporin 4; jTBI, juvenile traumatic brain 
injury; d, days post injury; * p<0.05, #p<0.06). 
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Taken together, these data suggest that the delayed increase in AQP4 expression 
at 7 d is possibly related to the edema resolution (Figure 8) during the first week post-
injury. However, by 60d when post-traumatic edema is no longer present, changes in 
AQP4 distribution may reflect other pathophysiological changes occurring near the lesion 
site and at distance from the impact (Ajao et al., in press). 
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Figure 8. Summary Schematic of the Relative Changes in ADC, T2, and AQP4 after 
jTBI. Summary Schematic of the Relative Changes in ADC, T2, and AQP4 at the region 
encompassing the site of impact: The values are normalized to the sham values, which is 
set at 0%. Notice the initial decrease of ADC and increase of T2, accompanied by a 
gradual increase in AQP4 values. As AQP4 increases, T2 and ADC start to normalize, 
signifying a possible resolution of edema. (AQP4, aquaporin 4; d, days post injury; ADC, 
apparent diffusion coefficient). 
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Absence of Astrocytic AQP9 Changes after jTBI 
Due to the involvement of several AQPs post-injury (Ribeiro Mde et al. 2006), we 
also evaluated the pattern of AQP9 in our model. AQP9 staining was observed in 
astrocytes of the corpus callosum (CC) and other white matter tracts such as the lateral 
olfactory tract (LOT) (Figure 7), in the astrocytes of the subfornical organs, tanycytes and 
ependymal cells as previously reported (Badaut et al., 2004). No significant differences in 
AQP9 staining were observed between the sham and jTBI animals at any time points. 
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Figure 7. Aquaporin 9 Sham vs jTBI. AQP9 showed no significant differences in 
intensity of staining or pattern of staining between sham and jTBI at any of the studied 
time points. (A1-A4) AQP9 staining of sham colocalized with DAPI and GFAP in the 
lateral olfactory tract. (B1-B4) AQP9 staining of jTBI colocalized with DAPI and GFAP 
in the lateral olfactory tract. (C1-C4) AQP9 staining of sham colocalized with DAPI and 
GFAP in the corpus callosum. (D1-D4) AQP9 staining of jTBI colocalized with DAPi 
and GFAP in the corpus callosum. (AQP9, aquaporin 9; GFAP, glial acidic fibrillary 
protein; jTBI, juvenile traumatic brain injury; LOT, lateral olfactory tract; CC, corpus 
callosum; scale bar = 100 μm). 
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Discussion 
Our data suggest that AQP4 plays a significant and more important role than 
AQP1 and AQP9 in regulating edema in the immature brain during the first week after 
jTBI. Similar to clinical observations, we observed a diffuse increase of brain water 
content and decrease of water mobility from regions close to, and far from, the lesion site 
in both hemispheres at 1 and 3d post-injury. By 7d, MRI values normalized in parallel 
with increases in AQP4 immunoreactivity, a pattern similar to stroke models (Ribeiro 
Mde et al., 2006, Badaut et al., 2007). At a distance from the lesion and primary sites of 
edema, we observed consistently higher AQP1 staining at 7, 30, and 60 d in neuronal 
filaments in the dorsolateral septum, thus highlighting the functional consequences of 
neuronal AQP1. 
Clinically, diffusion weighted imaging (DWI) and T2 weighted imaging (T2WI) 
are useful modalities in the assessment of injury severity and outcome, particularly for 
edema formation and resolution (Obenaus and Ashwal, 2008, Chastain et al., 2009, 
Badaut et al., 2011b). At 1d, we observed bilateral increases in water content (higher T2) 
and decreases in water mobility, as shown by lower ADC values (Figure. 1). It is known 
that widespread edema at sites distant from the original impact are more common in 
juvenile than adult patients. These changes may be associated with differential 
susceptibility to blood-brain barrier (BBB) breakdown  and cellular swelling following 
TBI (Pop and Badaut, 2011). Later, our ADC values returned to sham values by 3d but 
then increased by 30d, while T2 values normalized by 7d and remained stable. However, 
the pattern of acute ADC changes described in our study was not observed in a 
previously published paper using a rat jTBI model (Bertolizio et al., 2011). This 
discrepancy could be due to a difference in the magnet used for the MRI (11.7 T in our 
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study vs 4.7T) and also to the definition of the ROI used for analysis (Bertolizio et al., 
2011). In fact, few publications address both ADC and T2 changes in rodent jTBI. 
Comparable ADC and T2 changes to our animals were described in focal (Badaut et al., 
2007) and global (Meng et al., 2004) rat pup models of hypoxia-ischemia.  Overall, the 
patterns in our ADC and T2 data suggest that edema formation in the immature brain 
may have cytotoxic and vasogenic components at different post-injury timepoints.  
AQPs have been proposed to account for MRI changes reflecting edema 
formation/resolution in several rodent models of brain injury (Meng et al., 2004, Tourdias 
et al., 2009, Badaut et al., 2011a, Badaut et al., 2011b, Tourdias et al., 2011). Here, we 
provided an extensive evaluation of several AQPs at multiple timepoints after jTBI, to 
address distinctive profiles during the post-traumatic period in the immature brain. At 1d, 
we observed stable levels of AQP4 near the lesion and decreased AQP4 in the 
contralateral striatum, in spite of MRI changes occurring bilaterally throughout the brain 
hemispheres. One explanation may be that stable AQP4 levels adjacent to the site of 
impact may contribute to water entry leading to cellular swelling (lower ADC) and 
increased edema (increased T2).  At a distance, ADC changes may reflect cellular 
swelling secondary to reduced AQP4 (Figure 4), associated with transient water 
accumulation. Other models of normal or pathological brain show concomitant decreases 
in AQP4 expression and ADC (Meng et al., 2004, Badaut et al., 2011a), or increased 
AQP4 and ADC in hydrocephalus and inflammation models (Tourdias et al., 2009). 
Notably, a 30% decrease in AQP4 expression using small interference RNA led to a 50% 
decrease in ADC values in normal rats (Badaut et al., 2011a).  However, in neonatal 
stroke models (Badaut et al., 2007) and neuroinflammation in adult rats (Tourdias et al., 
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2011), decreased ADCs did not correlate with AQP4 at 1d, similar to the discrepancies in 
our model. These global changes and heterogeneity of AQP4 expression underlie the 
complexity of molecular changes behind the fluctuations in water content and mobility 
during the edema process after jTBI.  
Evidently, AQP4 may not be solely responsible for changes in water mobility 
associated with edema development after jTBI, suggesting the participation of other 
channel proteins. Two likely candidates are the gap junction protein Connexin-43 (Cx43) 
and inwardly rectifying potassium channel 4.1 (Kir4.1). Cx43 is down-regulated after 
silencing RNA against AQP4 in primary astrocyte cultures (Nicchia et al., 2005), while 
Kir4.1 co-localizes with AQP4 in astrocytic endfeet (Nagelhus et al., 2004). In addition, 
cellular potassium reuptake is impaired in an AQP4 knock-out epilepsy model (Binder et 
al., 2006) and potassium has been linked with water flux during astrocytic swelling 
(Dibaj et al., 2007). It is possible that AQP4, Cx43, and Kir 4.1 may be working in 
concert to address brain edema following jTBI. 
Edema is a complex molecular process as shown in previous studies examining 
post-TBI AQP expression in adult TBI models. Reports of increased AQP4 (Sun et al., 
2003, Guo et al., 2006, Ding et al., 2009, Higashida et al., 2011, Tomura et al., 2011) 
versus decreased AQP4 (Ke et al., 2001, Kiening et al., 2002, Zhao et al., 2005) are likely 
due to differences in injury type, rodent strains, and age at impact. We expect our 
juvenile cortical impact in P17 rats to differ from observations in adult animals, 
especially as early brain trauma may interfere with developmental phases and the 
evolution and mechanisms of injury. We observed increases in AQP4 at 3 and 7d near the 
lesion site in perivascular astrocyte endfeet, astrocyte processes, and the glia limitans. 
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These changes may indicate that excess AQP4 could facilitate edematous fluid 
elimination through the subarachnoid space (Papadopoulos and Verkman, 2007, Tait et 
al., 2010, Tourdias et al., 2011).  For example, increased AQP4 in the glia limitans may 
compensate for water accumulation at 1 and 3d (higher T2), with a gradual increase of 
AQP4 at 3d and normalization of both AQP and T2 values by 7d. This increase of AQP4 
at 3 and 7d also parallels the restoration of the BBB with decreased IgG extravasation at 
3d and no disruption by 7d (Pop and Badaut, 2011). Although AQP4 improves water 
removal, it can also regulate the initial formation of edema (based on increased T2 values 
at 1d) as previously proposed (Papadopoulos and Verkman, 2007, Tait et al., 2010). 
Thus, inhibiting AQP4 immediately after juvenile injury could be beneficial for edema 
reduction as shown in several other injury models (Manley et al., 2000, Papadopoulos 
and Verkman, 2005, Saadoun et al., 2008, Badaut et al., 2011b, Higashida et al., 2011, 
Igarashi et al., 2011).  
Disproportionate levels of AQP4 isoforms and their ratios may interfere with the 
protein’s function, due to incorrect formation of the orthogonal array of particles, as 
described in stroke models (Badaut et al., 2011b). Moreover, although there is no general 
consensus and it remains controversial in vivo, some data show that the M1 isoform may 
have a higher water permeability than the M23 isoform (Fenton et al., 2010). This 
difference in water permeability may account for significant increases in the M1 isoform 
alone during stroke-related edema (Hirt et al., 2009).  In our model, we detected higher 
protein levels of both isoforms on the impacted side compared to sham animals (Figure 
5), higher levels of M23 than M1 in both groups, and no changes in isoform ratios. 
Together, these data suggest that the individual orthogonal array of particle arrangement 
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may be similar between sham and jTBI by 7d, when the majority of edema and BBB 
disruption processes are nearly resolved. 
We provide an evaluation at delayed post-injury timepoints, in contrast to reports 
in the adult literature focusing on the acute phase. Although AQP4-IR intensity was 
similar at 60d between groups, the pattern of AQP4 staining was different in jTBI 
animals. Notably, fewer scattered areas of perivascular AQP4 staining were observed in 
the parietal cortex near the lesion site in jTBI compared to sham by 60d. Long-term 
changes of AQP4 have been observed in other models such as spinal cord injury (Nesic et 
al., 2010), mouse models of Alzheimer disease (Wilcock et al., 2009, Yang et al., 2011), 
and Alzheimer disease patients (Wilcock et al., 2009, Moftakhar et al., 2010). These 
findings strengthen the concept that AQP4 may have additional roles that are not edema-
related after certain injuries, such as cell migration (Saadoun et al., 2005, Auguste et al., 
2007). In human and rat models of spinal cord injury, the ratio of GFAP to AQP4 in 
astrocytes around the lesion depend on both the time after injury as well as the severity of 
injury (Nesic et al., 2010). Thus, it is possible that the gliovascular unit as a whole is 
chronically affected. Further long-term studies of the gliovascular unit after jTBI should 
evaluate phenotypic changes in astrocytic networks in microvascular trees and functional 
correlations of those changes.     
A few TBI studies describe increases in neuronal AQP1 (Tran et al., 2010, Oliva 
et al., 2011) and AQP9 (Ding et al., 2009, Oliva et al., 2011) after injury in adults. In our 
jTBI model, AQP1 expression in the choroid plexus did not differ between sham and 
jTBI at any time points. However, we found more intense AQP1 staining in neuronal 
filaments in the dorsolateral septum in jTBI animals at 7, 30, and 60 d. Neuronal septal 
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tracts are involved in a number of cognitive pathways including learning, memory, sexual 
behavior, positive reinforcement, and pain (Gallagher et al., 1995, Singewald et al., 
2011). Although consensus has not been established concerning the role of AQP1 in pain 
processing (Borsani, 2010), AQP1 knock-out mice had reduced pain responses versus 
wild-types (Oshio, 2006). TBI patients also report varying degrees of acute and chronic 
pain post-injury (Borsook, 2011; Nampiaparampil, 2008).  Thus, septal increases in 
AQP1 and their influence on pain processing may be further elucidated in this jTBI 
model, by using appropriate nociceptive testing paradigms.   
AQPs likely contribute to the evolution of several nervous system disorders, and 
can serve as potential therapeutic targets to improve clinical outcomes post-injury. Long-
term changes in AQP4 and AQP1 after jTBI highlight differences in the edema process 
occurring during a developmental period. Notably, edema can have different timelines for 
resolution in the young versus adult brain. Our data also confirm the importance of 
optimal timing for the administration of therapeutic agents targeting AQPs. While AQP 
therapies have been previously suggested for different pathologies such as stroke (Badaut 
et al., 2011b), optimal results can only be achieved when accounting for injury-specific 
parameters. It is important to consider age at injury (e.g. adult versus juvenile), type of 
injury model (e.g. cortical impact, fluid percussion, weight drop, craniotomy versus 
closed-head), and post-injury evaluation timepoints. Finally, no single model (e.g. TBI or 
stroke) can define the whole spectrum of a given pathology (e.g. edema) over time. 
Therefore, observational studies at multiple timepoints are valuable and necessary to 
adequately characterize post-injury sequelae, towards a comprehensive understanding of 
differential expression patterns of proteins involved in pathophysiological events. To 
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determine the exact contribution of AQP4 on edema formation and resolution in parallel 
with our observations, it will be necessary to pursue a more functional study directed 
towards blocking or increasing AQP4 expression.   
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Abstract 
Traumatic brain injury (TBI) is common in young children and adolescents and is 
associated with long-term disability and mortality. The neuropathological sequelae that 
result from juvenile TBI are a complex cascade of events that include edema formation 
and brain swelling. Brain aquaporin 4 plays a key role in edema formation. Thus, 
development of novel treatments targeting aquaporin 4 to reduce edema could lessen the 
neuropathological sequelae. We hypothesized that inhibiting aquaporin 4 expression by 
injection of small interference RNA targeting aquaporin 4 (siAQP4) after juvenile 
traumatic brain injury would decrease edema formation, neuroinflammation, neuronal 
cell death, and improve neurological outcomes. 
siAQP4 or a non-targeted-siRNA (siGLO) was injected lateral to the trauma site 
after controlled cortical impact in postnatal day 17 rats. Magnetic resonance imaging, 
neurological testing, and immunohistochemistry were performed to assess outcomes. 
Pups treated with siAQP4 showed acute (3d post-injury) improvements in motor 
function and spatial memory at long-term (60d post-injury) compared to siGLO-treated 
animals. These improvements were associated with decreased edema formation, 
increased microglial activation, decreased blood-brain barrier disruption, and reduced 
astrogliosis and reduced neuronal cell death. The effectiveness of our treatment paradigm 
was associated with a 30% decrease in aquaporin 4 expression at the injection site.  
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Introduction 
Traumatic brain injury (TBI) affects about 1.7 million people annually and 
contributes to 30% of all injury-related deaths in the United States. An important sub-
group are injured children (ages 0-14) of which a half million require treatment in local 
emergency departments.(1) Despite this increasing incidence of juvenile traumatic brain 
injury (jTBI), there are currently no effective pharmacological treatments. 
TBI is divided into two main types of injuries: primary injuries due to a direct and 
immediate mechanical disruption of brain tissue; and secondary injuries, a matrix of 
delayed events affecting neuronal, glial, and vascular structures.(2) The severity of 
primary injuries has decreased in recent years due to increased public and legislative 
awareness concerning preventative measures such as regulation of motor vehicle speed 
limits and wearing protective helmets during competitive sport activities. Thus, 
development of effective post-injury treatments should focus on targeting secondary 
injury cascades. This is especially important in jTBI because the brain is still undergoing 
development and secondary injuries are more severe in the pediatric than in adult 
population with long lasting cognitive, emotional, and motor effects.(3) Secondary 
injuries including blood-brain barrier (BBB) disruption and edema formation are 
pathological hallmarks after jTBI and contribute to the myriad of long lasting 
consequences of jTBI(4), and make excellent clinical targets for improving outcome. We 
recently characterized the behavioral changes, brain tissue properties, as well as 
neurovascular unit transformation up to 60 days after a controlled cortical impact in 
juvenile rats (post-natal 17 days old) (5-7). 
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Aquaporin 4 (AQP4) is mainly expressed in perivascular astrocytic endfeet and is 
the most abundant brain aquaporin and has been shown to play a central role in edema 
formation in several cerebrovascular diseases.(8) However, the beneficial or deleterious 
role of AQP4 in edema formation remains unclear and depends on the pathological 
model(9). We recently showed an increase in edema formation at 1 and 3 days post-
injury with concomitant decreased apparent diffusion coefficient (ADC) and increased T2 
values in a model of jTBI (6). These MRI changes were associated with increase of the 
AQP4 expression at 3d, suggesting a central role of AQP4 in edema formation in jTBI 
(6). Nonetheless, several studies using AQP4 knockout mice have shown significant 
decreases in edema formation in several injury models, including adult TBI.(10) Despite 
several recent reports proposing the use of ionic channel inhibitors to block AQP4 
channels(11) and pretreatment with certain drugs(12), there are no specific AQP 
inhibitors available for clinical use.(8) Recently, small interfering RNA (siRNA) to 
transiently knockdown proteins of interest has garnered considerable translational 
attention with improvements noted in clinical trials using siRNA against VEGF receptors 
for the treatment of cancer (13). In our group, we have recently shown that siRNA 
against AQP4 (siAQP4) can effectively reduce brain AQP4 expression in vitro and in 
vivo(14). In the present study, we hypothesized that using siAQP4 injection as a 
treatment to decrease AQP4 expression after controlled cortical impact (CCI) in juvenile 
rats would decrease edema formation, BBB disruption and neuroinflammation 
(astrogliosis and microglia activation) as well as improve neurological outcomes. 
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Materials and Methods 
Animals 
Manuscript was written in accordance with the ARRIVE guidelines. Experiments 
and care of animals were conducted according to the principles and procedures of the 
Guidelines for Care and Use of Experimental Animals and were approved by the Loma 
Linda University Institutional Review Board. Sprague Dawley rat pups at postnatal day 
17 (P17) were housed in a temperature controlled (22-25
o
C) animal facility on a 12-hour 
light/dark cycle 7 days before the surgery. 
  
siRNA Preparation 
An in vivo AQP4 silencing protocol was adapted as described in our previous 
studies.(14) Briefly, SMART-pool® containing 4 siRNA-duplexes against AQP4 (400ng, 
siAQP4, Dharmacon Research) and non-targeted siRNA (siGLO RISC-free-control-
siRNA, Dharmacon Research) were mixed with interferin® (Polypus-transfection, 
Illkirch, France) diluted in a saline solution (0.9%) containing 5% glucose for a final 
volume of 5 L and incubated on ice for 20 min before injection. 
  
Controlled Cortical Impact (CCI) Injury  
and siRNA Injection 
 
Controlled cortical impact (CCI) was carried out in P17 rat pups as previously 
described.(5)  Rats were anesthetized with isoflurane (2%) and placed in a stereotaxic 
apparatus (David Kopf Instrument, Tujunga, USA) where a 5 mm diameter craniotomy 
was performed over the right hemisphere at 3 mm posterior from the bregma and 4 mm 
lateral to the midline. Animals were subjected to a CCI with a 2.7 mm round tip angled 
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20 degrees at a velocity of 6 m/s to a depth of 1.5 mm below the cortical surface using an 
electromagnetic impactor (Leica, Richmond, IL). After craniotomy, the dura was intact in 
both groups and after induction of TBI none of the animals in siGLO and siAQP4 groups 
had major bleeding or herniation of cortical tissues. 
Injection of siRNA was performed 10 min after the injury lateral to the site of the 
impact using a 30-gauge needle on a Hamilton syringe (3 mm posterior to bregma, 6 mm 
lateral to midline, and 1.0 mm below cortical surface). The syringe was attached to a 
nanoinjector (Leica, Richmond, IL) and a volume of 4 L of siRNA was infused at a rate 
of 0.4 L/min. After suturing, all pups received an intraperitoneal injection of 
buprenorphine (0.01 mg/kg, Tyco Healthcare Group LP, Mansfield, MA) for pain relief 
and then placed on a warm heating pad for recovery before being returned to their dams. 
A second siRNA injection was repeated 2 days later in all pups using the same injection 
protocol. Total number of animals used for the study was 27 rats divided in n=15 rats for 
siGLO and n=12 for siAQP4 group. 
 
Magnetic Resonance Imaging (MRI) 
MRI was performed at 1 and 3d. Pups were lightly anesthetized using isoflurane 
(1.0%) and imaged on a Bruker Avance 11.7 T (Bruker Biospin, Billerica, MA).(15) Two 
imaging data sets were acquired: 1) a 10 echo T2- and 2) a diffusion weighted imaging 
(DWI) sequence in which each sequence collected 20 coronal slices (1 mm thickness and 
interleaved by 1 mm). The 11.7T T2 sequence had the following parameters: TR/TE = 
2357.9 / 10.2 ms, matrix = 128 x 128, field of view (FOV) = 2 cm, and 2 averages. The 
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DWI sequence had the following parameters: TR/TE = 1096.5 / 50 ms, two b-values 
(116.960, 1044.422 s/mm
2
), matrix = 128 x 128, FOV = 2 cm, and 2 averages.  
 
Region of Interest (ROI) and Volumetric Analysis 
T2 and apparent diffusion coefficient (ADC) values were quantified using 
previously published standard protocols (14). Regions of interest (ROIs) were placed on 
the imaging section with the maximally detected injury using Cheshire (Parexel 
International Corp. Waltham, MA). Lesion and ipsilateral hippocampus were delineated 
on T2 images and overlaid onto corresponding T2 and ADC maps. The mean, standard 
deviation, and area for each ROI were extracted. 
 
Behavioral Testing 
The behavioral evaluation was performed on 2 independent sets of animals. Foot-
fault and rotarod testing was performed at 1, 3, 7 and 60 days, where the foot-fault test 
evaluated sensorimotor and proprioception while the rotarod test evaluated sensorimotor 
coordination as previously reported in our earlier studies.(5) All tests at each time-point 
were carried out on siGLO and siAQP4 treated jTBI rats within a 3-hours morning time-
block (8 – 11 am).  siGLO and siAQP4 treated jTBI rats were interleaved in testing 
sequence. To further control potential confounds, the same tests were administered in the 
same order at all of the time points, by the same investigators (AA, VP, JC) blinded to the 
experimental groups. For the behavioral tests the videos and the extraction of the data 
were carried out by JB and RH, who were also blinded to the experimental groups. 
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Foot-fault testing was carried out on an elevated platform (50 cm X 155 cm, 
ClosetMaid, Ocala, FL) with parallel wire bars 1.5 cm apart and raised 100 cm above the 
floor at 1d, 3d, 7d, and 60d. Rats were placed in the middle of the platform and 
movements were video-recorded for a period of 60 sec. in two separate trials, 30 min. 
apart. When a rodent’s paw (fore- or hindlimb) slipped completely through the wire 
mesh, it was considered as an individual fault. The average foot-fault score was 
calculated from the total number of faults from two 60 sec trials.   
Rotarod evaluation was performed on all the animals at 1d, 3d, 7d, and 60d (SD 
Instruments, San Diego, CA). A rotating 7 cm-wide spindle with a continuous speed (20 
RPM) was used to evaluate performance during two trials (15 min apart). Latency to fall 
was recorded as a measure of motor coordination and balance. The maximum time spent 
on the test was 60s, if the rat did not fall. The two fall latencies were summed and express 
in total time (s) for 2 trials. 
At 60 days post injury a battery of tests were performed over 4 days to evaluate 
the overall cognitive performance of the animals including open field, zero maze, and 
Morris Water Maze (MWM) (5). 1) Open field was used to assess the overall locomotor 
activity in a plastic box (50 x 36 x 45 cm), and each rat was monitored for 30 min with an 
overhead video camera using Noldus Ethovision software (Tacoma, WA). The total 
distance traveled by each rat was recorded (5). 2) On day 2, the elevated zero maze tests 
used an elevated circular track 10 cm wide with a 100 cm outer diameter and 2 sets of 30 
cm high walls enclosing two opposing quadrants of the track, leaving the other two 
opposing quadrants open and brightly lit. This test was used to evaluate anxiety-like 
behavior by a 5 min observation, and the outcome measure was the percentage of the 
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time spent in the enclosed (dark) half of the maze. 3) Finally, the MWM test was carried 
out to assess spatial learning and memory in the rats. The test consists of a tank of 100 
cm in diameter, filled with opaque water and an 11 cm diameter escape platform was 
placed. Recording the animal with an overhead camera and the Noldus Ethovision system 
allowed for assessment of variables such as swim distance, swim speed, and relative 
angular velocity (left / right turn bias). The first day of testing consisted of the cued 
learning paradigm, designed to test for non-associative factors that could affect the 
scoring on the MWM, such as motivation, swimming ability, and vision. The platform 
was visible by protruding 2 cm above the waterline with a 40 cm wooden rod attached. 
Animals were placed in the tank and required to simply swim to the visible platform to 
end the task. Each animal completed 10 trials consisting of 5 blocks of 2 trials each, with 
their starting location and that of the platform being shifted throughout the task. If the rat 
had not found the platform after 60 sec, it was guided to the platform, where it remained 
for 5 seconds. The swim path was recorded and each animal’s total swim distance 
determined for each trial. The following days 2 and 3 of the MWM consisted of the 
spatial paradigm, designed to measure an animal’s ability to learn and remember a hidden 
platform’s location in the tank. During this paradigm, the platforms submerged 
approximately 2 cm below the water’s surface, and release points varied throughout each 
day although the platform remained stationary. As in the cued paradigm, animals were 
required to swim to the platform to end the task. Unlike the cued paradigm, hiding the 
platform’s surface under the water’s surface required animals to learn and navigate to the 
location using spatial cues. Each animal completed 10 trials consisting of 5 blocks of 2 
trials each. If the animal had not found the platform after 60 sec, it was guided to and 
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placed on the platform, where it remained for 5 seconds. The dependent variable for the 
spatial task was cumulative distance to the platform, a variable sensitive to both distance 
and time defined as a cumulative total of an animal’s distance from the platform as 
measured 5 times every second. After each day of spatial testing, a probe trial was 
administered to measure an animal’s ability to remember the platform’s location. This 
trial was administered 1 hour after the final spatial trial of the day. The platform was 
removed and animals were allowed to search the tank for 60 sec. Dependent variables for 
this task included the number of times an animal entered the platform’s previous location 
and percent time spent in the target quadrant. 
 
Immunohistochemistry and Image Analysis 
At 3d the animals were transcardially perfused with 4% paraformaldehyde, the 
brains extracted and put in 30% sucrose for 48 hours and then stored in -22°C. Coronal 
sections were cut at 20 μm thickness at -22°C on a cryostat (Leica, Richmond, IL) and 
mounted on slides for immunohistochemical analysis (14-16).   
For immunoglobulin (IgG) extravasation immunohistochemistry, sections were 
washed with PBS, blocked with 1% BSA in PBS, then incubated for 2 hours at room 
temperature with IRDye 800 conjugated affinity purified goat-anti-rat IgG (1:500, 
Rockland, Gilbertsville, PA) in PBS containing 0.1% Triton X-100 and 1% bovine serum 
albumin. After washing, sections were scanned on an infra-red (IR) scanner (Odyssey) to 
quantify fluorescence for the different ROIs as previously described.(14) Additional 
immunostaining was done for rabbit polyclonal antibodies for AQP4 (1:300, Alpha 
Diagnostic, Owings Mill, MD), chicken polyclonal antibodies for glial fibrillary acidic 
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protein (GFAP, 1:500, Millipore, Billerica, MA), mouse monoclonal antibodies for 
endothelial brain antigen (EBA, 1:1000, Covance, Princeton, NJ), mouse monoclonal 
antibodies for Neuronal Nuclei (NeuN, 1:200, Abcam, Cambridge, MA), rabbit 
polyclonal antibodies for ionized calcium-binding adapter molecule (Iba-1, 1:300, Wako, 
Richmond, VA), and mouse monoclonal antibodies for Claudin-5 (1:200, Invitrogen, 
Carlsbad, CA) were used. Sections were washed with PBS, blocked with 1% BSA in 
PBS, incubated with the respective primary antibodies overnight, then incubated with 
affinity purified secondaries conjugated to the desired wavelength to either be scanned on 
an IR scanner or to be observed under a confocal microscope (Olympus). All image 
acquisition parameters for the same proteins were kept constant for all of the animals for 
analysis and visualization purposes. All analysis was carried out in a non-biased, blinded 
manner. AQP4, GFAP, Claudin 5, and Iba-1 were quantified in a similar manner to IgG 
extravasation staining as published previously (14). In detail, slides were incubated with 
secondaries conjugated to the infrared wavelength of either 680 or 800 nm. These slides 
were then scanned on an infrared scanner (Odyssey, Lincoln, NE), where images were 
saved with resolution of 21 μm per pixel. Three identical circular regions of interests 
(ROIs) were drawn in the perilesional cortex (Fig. 3A) at three different bregma levels (-
1.40mm, -2.56mm, and -3.80mm): the bregma level where lesion area was largest, one 
slice anterior and one posterior, for a total of 9 regions of interests per animal. The 
average fluorescence of these regions of interests was calculated. EBA and NeuN 
staining was quantified using the Mercator software (Explora-Nova, La Rochelle, 
France). The area of EBA staining was measured by drawing an ROI on the acquired 
image with the largest legion as determined and confirmed by MRI, and the total area of 
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EBA-positive staining was determined and that value was divided by the area of the ROI. 
Thus, the % of staining per given area was determined for each animal. NeuN positive 
cells were counted on images acquired using constant parameters: i.e. the same values of 
the contrast, gain, and brightness were used. Similar to EBA analysis, the tissue section 
with the largest legion was selected and the NeuN positive cells were counted in an 
automated fashion via the Mercator software and the density was determined. Microglial 
activation was quantified by calculating the average form factor (FF= 4π*area/perimeter2 
of each cell) from the Iba-1 positive cells using the image software, MorphoPro (Explora-
Nova) on images acquired using constant parameters: i.e. the same values of the contrast, 
gain, and brightness were used. Negative control staining where the primary antibody or 
secondary antibody was omitted showed no detectable labelling.  
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Figure 3. siAQP4 treatment decreases Blood-Brain Barrier disruption after jTBI. Drawing 
of the region of interests (ROIs) used in the study to quantify protein and histological 
changes in correlation with the MRI measurements (A). Representative 
photomicrographs of IgG-extravasation immunofluorescence (arrows) in siGLO (B) and 
siAQP4 (C) treated rat pups. siAQP4 treated rat pups showed significantly decreased 
IgG-extravasation staining adjacent to the lesion site compared to siGLO-treated animals 
(*, p<0.05), suggesting that the siAQP4 treatment mitigates BBB disruption (D). 
Endothelial Barrier Antigen (EBA) is a marker of intact endothelial cells in rats and 
disappears when the endothelial layer is disrupted. The arrows in (E) show blood vessels 
(asterisks) devoid of EBA staining in siGLO treated animals. In contrast siAQP4 rat pups 
had more EBA-positive staining (arrowheads) in the cortical perilesion tissue (F). 
Quantification of the EBA staining showed that the siAQP4 treated rat pups had more 
EBA-positive staining (arrowheads), suggesting decreased damaged blood vessels in the 
perilesion tissues (*, p<0.05) (G). This result is in accordance with the IgG extravasation 
data showing improvement of the BBB after siAQP4 treatment (A-C). Similarly, claudin-
5 staining, a tight junction protein (in green H, I) showed increased staining in siAPQ4 (I, 
arrows) compared to siGLO treated rats (H, arrows) and confirmed in the quantification 
of claudin 5 immunoreactivity (*, p<0.05) (G). Increased levels of claudin-5 suggest less 
BBB disruption consistent with decreased IgG extravasation and increased EBA staining 
after siAQP4 treatment.  Taken together, siAQP4 treatment results in less BBB disruption 
at day 3 after injury as seen by more tight junction proteins, more intact blood vessels, 
and less leakage of IgG from the peripheral blood vessels to brain tissue.   
Scale bars in A, B=3mm; D, E=100µm. 
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Brain Tissue Processing for Western Blotting 
A Protein FFPE extraction kit (Qiagen, Hilden, Germany) was used to process 
perfused brain slices for Western blotting as previously published (7). Parietal cortical 
tissue around the lesion was excised from three coronal sections at bregma levels -1.40, -
2.56 and -3.80mm, that were adjacent to slices of interest used for immunohistochemistry 
quantification. Briefly, tissue was homogenized and processed according to kit 
instructions, and then samples were assayed for total protein concentration by 
bicinchoninic acid assay (BCA, Pierce Biotechnology Inc., Rockford, IL). For gel 
electrophoresis, all samples were prepared with loading sample buffer and reducing agent 
(Invitrogen, Carlsbad, CA) for a total of 2 µg of rat protein loaded on a 4-12% SDS 
polyacrylamide gel (Nupage, Invitrogen, Carlsbad, CA). Proteins were transferred to a 
polyvinylidene fluoride membrane (PVDF, PerkinElmer, Germany), blocked for 1 hr in 
Odyssey blocking buffer (Li-Cor Bio-Science, Lincoln, NE), and incubated with a rabbit 
polyclonal anti-AQP4 (1:3000; Alpha Diagnostic, Owings Mill, MD) and mouse anti-
tubulin (1:10,000; Sigma-Aldrich Co., St. Louis, MO), and these blots were co-incubated 
with goat anti-mouse secondary antibody coupled with Alexa-Fluor-800 (1:10,000; 
Rockland Immunochemicals, Gilbertsville, PA) and goat anti-rabbit secondary antibody 
coupled with Alexa-Fluor-680 (1:10,000; Life Technologies: Molecular Probes, Grand 
Island, NY) for 2 hrs at room temperature. After PBS washes, the PVDF membrane was 
visualized using the Li-Cor infra-red scanner and fluorescence activity was directly 
quantified Odyssey software (Li-Cor, Bioscience). 
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Statistics 
 MRI and behavioral data were analyzed by two-way repeated measures analysis 
of variance with a post hoc Bonferroni test. One-way ANOVA was used for 
immunohistochemistry and western blot analysis. All data are expressed as the mean ± 
SEM. 
 
Results 
siAQP4 Treatment Reduces AQP4 Expression Acutely 
Injection of siAQP4 induced a 31% decrease (p<0.05) in the level of AQP4 
expression at 3d (Fig. 1A, B). In support of the Western blot results, siAQP4 treated rats 
showed a 27% decrease in AQP4 staining within the perilesional tissues around the 
cavity on the ipsilateral cortex as well as a 33% decrease in the ipsilateral hippocampus 
compared to siGLO-treated animals (p<0.05) (Fig 1C-G). This decrease in AQP4 staining 
after jTBI was of similar magnitude to that which we previously reported in normal (i.e. 
no jTBI) juvenile brain tissues after siAQP4 injection(14). In contrast, Western blot and 
immunohistochemistry analysis showed no differences in AQP4 expression between 
siGLO and siAQP4 treated animals at 60 days (Fig 6A, B, C). No significant changes 
found in the contralateral cortex or hippocampus at 3 and 60 days (data not shown). 
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Figure 1. Reduced Expression of AQP4 after siAQP4 injection. AQP4 Western blot from 
adjacent PFA fixed sections in siGLO and siAQP4 groups showed a band around 34 kDa, 
with a decrease of the intensity in siAQP4 treated group. Tubulin was used to normalize 
the loading. The quantification of the intensity of the band showed a significant decrease 
of AQP4 (p< 0.05). Representative images of AQP4-immunoreactivity in the cortical 
perilesion and hippocampus adjacent to the jTBI cavity (*) in siGLO (C) and siAQP4 
treated animals (D) at low magnification. AQP4 staining bordering the cavity is 
decreased in the siAQP4 (D) compared to the siGLO treated animals (C) at d3 post-
injury. Similarly, the AQP4-immunoreactivity is increased in the ipsilateral hippocampus 
of siGLO group (C) compared to siAQP4 treated animals (D). At higher magnification in 
perilesional cortex (Cx), AQP4 staining is predominant on astrocyte endfeet in contact 
with blood vessels (arrows, as previously described, (16)) in siGLO (E) and siAQP4 (F) 
animals, with decreased staining of AQP4 in the siAQP4 group. This suggests that the 
siAQP4 treatment after jTBI prevents the increase of AQP4 expression on astrocyte 
endfeet. (G) AQP4 immunoreactivity was quantified and confirmed a significant 
decrease in AQP4-immunoreactivity in the siAQP4 compared to siGLO treated rats in 
both the perilesional cortex and ipsilateral hippocampus (*, p<0.05).  Taken together, 
after jTBI, siAQP4 injection induced a decrease of AQP4-immunoreactivity acutely. 
Abbreviation: Cx, cortex; scale bars C, D = 1mm; E, F=100μm. 
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siAQP4 Treatment Reduces Acute Edema Formation 
 As determined by 1d and 3d MRI, we found decreased T2 (edema) and ADC 
(water mobility) values in siAQP4 compared to siGLO-treated pups (Fig 2), strongly 
suggesting that siAQP4 reduced edema formation. Whereas T2 values increased in the 
lesion/perilesion area of siGLO treated rats they were decreased in siAQP4 pups from 1d 
to 3d (22% in the lesion/perilesion and 15% in the ipsilateral hippocampus). ADC values 
were also decreased by 21% in the lesion/perilesion at 1d (p <0.005) and by 24% in the 
ipsilateral hippocampus at 3d (p < 0.001) in the siAQP4 compared to siGLO-treated rats 
(Fig 2). Overall, the data suggest an association between the regions showing reduced 
AQP4 staining and reduced edema formation (T2) and improved tissue characteristics 
(ADC) (Fig 1 and 2). 
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Figure 2. Quantitative neuroimaging of jTBI after siAQP4 treatment reveals decrements 
in edema. Representative T2 images at day 3 in siGLO and siAQP4-treated pups show 
decreased edema at the lesion site following siAQP4 treatment (arrows) (A). siAQP4 
pups had significantly decreased edema (*, p < 0.001) compared to siGLO pups within 
the lesion at day 3 (B). There was also a significant decrease in edema after siAQP4 
treatment at day 3 within the hippocampus, ventral to the injury (*, p<0.001) (b). Water 
mobility (apparent diffusion coefficients, ADC) was reduced in the siAQP4 treated pups 
(day 1 after injury, arrows) (C). Quantitative ADC revealed significantly decreased water 
mobility in siAQP4 pups in the lesion at 1 day after injury compared to siGLO (*, p < 
0.001) (D). siAQP4 pups had significantly decreased ADC in the hippocampus at day 3, 
but not at 1 day (*, p < 0.001) (D).  After jTBI, siAQP4 injection mitigated the edema 
formation associated with a decrease of the AQP4 (Fig 1). 
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Reduced BBB Disruption in siAQP4 
Treated Rat Pups 
 
Edema formation (i.e. increased T2 values) also appeared to be associated with 
BBB disruption, which improved after siAQP4 treatment.  BBB integrity was assessed 
with claudin-5 (tight junction protein), endothelial barrier antigen (EBA) and IgG 
extravasation staining in the perilesional cortex and ipsi-hippocampus (Fig 3). Less BBB 
disruption was also shown through decreased IgG extravasation staining intensity by 30% 
around the site of the injury in the siAQP4 group (p<0.05) (Fig 3B, C, D). Associated 
with decreased IgG staining, a 31% increase in the area of EBA staining in siAQP4 rats 
was observed (Fig 3E, F, G).  Similarly, Claudin-5 immunoreactivity was higher in the 
siAQP4-treated animals around the cavity (Fig 3H, I, J).   
 
Reduced Astrogliosis, Increased Microglial Activation,  
and Increased Neuronal Survival in siAQP4 Treated Rat Pups 
 
The effects of siAQP4 on neuroinflammation were evaluated by measurement of 
astrogliosis with GFAP-immunoreactivity (Fig 4) and microglia activation with Iba-1 
staining (Fig 4). GFAP staining intensity was decreased by 39% around the cavity and by 
26% in the ipsilateral hippocampus of siAQP4-rat pups compared to the siGLO group 
(p<0.05, Fig 4). In contrast, we observed an increase in the number of activated 
microglial cells, showing amoeboid shapes with less ramifications in the lesion site 
characterized by higher calculated form factor (FF) in siAQP4 compared to siGLO 
treated rats (Fig 4). This observation was also supported by a higher intensity of Iba-1 
staining, a specific marker of microglia, using infrared analysis (Fig 4). No significant 
differences were observed in the ipsilateral hippocampus.
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Figure 4. siAQP4 treatment reduces astrogliosis and results in microglial activation 
acutely after jTBI. Increased GFAP staining after injury is a marker of reactive astrocytes 
and astrogliosis associated with neuroinflammation. Representative images of regional 
GFAP-immunoreactivity in the cortical perilesion in the siGLO (A) and siAQP4 treated 
animals (B). GFAP staining in the region bordering the cavity (*) is decreased in the 
siAPQ4 treated rats compared to the siGLO-treated animals at day 3 post-injury. 
Similarly in the hippocampus, the presence of GFAP staining in the reactive astrocytes in 
the siGLO treated rats (A) is increased compared to siAQP4 treated animals (B). At 
higher magnification, increased GFAP positive cells with swollen cell bodies and 
processes in the siGLO group (arrows, C) compared to siAQP4 (D) treated rats were 
observed in the perilesional cortex. The infrared intensity of the GFAP immunoreactivity 
was quantified and showed a significant decrease of GFAP staining in the siAQP4 
compared to siGLO treated rats in both the perilesional cortex and ipsilateral 
hippocampus (E) (*, p<0.05).  The significant decrease of GFAP in the siAQP4 treated 
rats suggests that siAQP4 treatment mitigates astrogliosis and the swelling of the 
astrocytes after jTBI. Immunoreactivity of Iba1 (red), a specific marker of microglia, 
showed a higher intensity of staining in the siAQP4 group (F) compared to siGLO-treated 
rats (G). At higher magnification, Iba1 staining presents different morphological patterns 
between the two groups, suggesting that the microglia cells do not have the same level of 
activation. In the siGLO group (I) Iba1 positive cells appear more ramified (arrows) and 
have less amoeboid-like shapes than microglial cells in siAQP4 treated rats (J, arrows). 
The amoeboid-like shapes observed for Iba1 positive cells in the siAQP4-treated group 
(J, arrows) are associated with a more activated microglia phenotype. To quantify the 
morphological differences, form factor (FF) analysis was performed where a higher FF 
correspond to a less ramified and more round cells, suggesting a more activated state for 
microglia. FF analysis revealed that siAQP4-treated rats had a significantly higher 
average FF compared to siGLO group (K) (*, p<0.01) consistent with a more activated 
microglia in siAQP4 animals. Infrared analysis showed higher intensity fluorescence in 
the siAQP4 animals compared to siGLO at the lesion site (H) (*, p<0.05).  
Scale bars in A, B =1mm; C, D =100µm, F, G, I, J = 20 µm. 
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The effects of siAQP4 on neuronal survival was also measured by counting the 
number of NeuN positive cells (5, 17). At 3d, NeuN positive cells were higher in the 
perilesional cortex adjacent to the cavity (62%) as well as in the ipsilateral hippocampus 
(56%) in the siAQP4 compared to siGLO-treated pups at 3d (Fig 5).  
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Figure 5. siAQP4 treatment increases neuronal survival at 3d post-injury. NeuN 
(Neuronal Nuclei) stained sections show a higher staining in the siAQP4 animals (D, E, 
F) than the siGLO (A, B, C) in the cortex (A, B, D, E) and the hippocampus (A, C, D, F) 
adjacent to the cavity (*).  Neuronal cell counts revealed a significant increase in the 
number of NeuN positive cells (# of cell/mm
2
) in both the perilesion (arrows A, D) and 
hippocampus (arrowheads, A, C, D, F) of siAQP4 animals (G) (*, p<0.05), suggesting 
improved neuronal survival after injury in siAQP4 treated rat pups compared to siGLO 
group. Scale bar A, D = 1.25mm; B, E = 50 µm; C, F = 20 µm. 
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At 60d, there were no differences in AQP4 and GFAP staining (Fig 6A, B, and 
C). No changes in microglial activation were observed at 60d (Fig 6D). In contrast there 
was a significantly higher number of NeuN positive cells in the CA1 region of the 
ipsilateral hippocampus in siAQP4 animals compared to siGLO, however no changes 
were observed in the ipsilateral cortex (Fig 6F, G, I).  
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Figure 6. siAQP4 treatment increases the neuronal survival in hippocampus at 60d. 
At 60d, AQP4 expression did not differ significantly between siAQP4 and siGLO as 
quantified via Western Blot (A) (B). AQP4 and GFAP staining did not show overall 
obvious visible differences in staining intensity or staining pattern between the groups as 
shown in the exemplary confocal picture (C). The arrows represent penetrating arteries 
stained in both siGLO and siAQP4 (C). At 60d, there were no visible differences in 
microglial staining visualized via Iba-1 immunohistochemistry between the siGLO and 
siAQP4 animals (D). Form factor analysis showed no significant differences between the 
animals, signifying no differences in microglial activation status (E). In the perilesional 
cortex of 60d animals, NeuN cell count showed no significant differences (F) (I). 
However, in the perilesional CA1 (arrow), siAQP4 animals had significantly higher 
number of NeuN positive cells (G) (*, p<0.05, I). A schematic drawing showing the 
regions of interests (in red) used to quantify NeuN numbers are shown (H). Scale bar C, 
D=50μm; F, G=100μm. 
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Improved Sensorimotor, Proprioception and  
Spatial Memory after siAQP4 Treatment 
 
Concomitant with the observed decrease in edema and histological improvements, 
motor functions were improved in siAQP4 treated rats. siAQP4 pups had fewer foot-
faults at 1 and 3d (respectively 34% and 46%, p < 0.05, Fig 7A). After 7d, there were no 
more significant differences in the number of foot faults (Fig. 7A). Similarly, siAQP4 
treated rats were able to stay on a rotarod 40% longer than siGLO treated rat pups at 3d 
(Fig 7B), that returned to baseline at 7d post injury. Long-term improvements were tested 
up to 60 days post injury, with a battery of tests assessing several cognitive repertoires. 
The open field test did not show significant difference between the groups in overall 
locomotor activity (data not shown) and supported the MWM cued test showing no 
differences in the ability to swim (data not shown).  Similarly, the zero maze tests did not 
show differences between the groups with the same time spent in the “dark” quadrants 
(data not shown). During the spatial learning on the day1 of the protocol, both groups 
were able to perform the task similarly (Fig 7C). However on the second day of the 
MWM protocol, when the platform is moved to a second location, siAQP4 animals spent 
more time than the non-treated group in trying to find the new location of the platform on 
the first block (Fig 7D). This suggests that siAQP4 animals have a better memory of the 
previous platform location and thus spent more time at the previous site (Fig 7E). This 
data is also supported by the probe test to assess the spatial memory. The siAQP4 treated 
rats spent significantly longer times than the siGLO group in the quadrant that previously 
contained the platform (Fig 7F).  Improvement in spatial memory at 60d post-injury is 
associated with higher CA1 neuronal survival in siAQP4 treated group (Fig 6). 
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Figure 7.  siAQP4 treatment associated with behavioral improvement at short and long-
term after jTBI. siAQP4-treated pups had better functional outcomes as revealed by the 
foot-fault test. siAQP4 group had significantly fewer foot faults than siGLO treated 
animals at day 1 (34%) and day 3 (46%) after jTBI (*, p < 0.05) (A).  siAQP4 animals 
also performed significantly better on the rotarod test at day 3 compared to siGLO by 
staying on for a significantly longer time before falling (*, p<0.05) (B). After jTBI, 
siAQP4 treatment improves the proprioception and sensorimotor outcomes in association 
with a better neuronal and a decreased edema formation acutely. In MWM test, the 
groups did not show overall significant difference in the rate of spatial learning at day 1 
(d1, C) and day 2(d2, D). However, the siAQP4 treated animals exhibited higher 
cumulative distance value on the first block on d2 (arrows) compared to the non-treated 
group, suggesting a better memory of the platform’s previous location. The video track 
(E, dark line) shows that the siAQP4 animals spent more time in the quadrant of 
platform’s previous location (location noted by blue dotted circle) than the siGLO rats, in 
accordance with a better memory. The actual location of the platform is noted by the red 
circle (E) and at the opposite location to the previous one. The probe test confirmed this 
hypothesis with a significantly higher time spent in the quadrant where the platform was 
located for the siAQP4 treated rats compared to the siGLO animals (F). All these data 
showed that siAQP4 treatment improve the short and long-term behavioral outcomes.   
In summary (G1 and G2), the primary injury induces a cascade of secondary of injuries 
involving AQP4 and water flow in brain tissue, which contributes to the edema formation 
(measured with T2 and ADC) and BBB disruption after jTBI.  Downstream to these 
changes, there is neuroinflammation with astrogliosis and microglia activation, 
accompanied by neuronal cell death during the first days after the injury. The neuronal 
cell death is associated with functional impairments (G1). The injection the siAQP4 after 
jTBI (G2) induces a decrease in the AQP4 expression, which contributes to less entry of 
water and edema (measured with T2 and ADC) and also fewer constraints on the BBB. 
Therefore, these changes are associated with less astrogliosis and higher activation of the 
microglia, which could be beneficial. With these improvements, the neuronal survival is 
improved and accompanied by a better functional recovery after siAQP4 treatment (G2). 
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Discussion 
We report here for the first time that siAQP4 treatment is an effective mechanism 
for reducing edema after jTBI and improves functional recovery even up to 60 days after 
injury. Injection of siAQP4 reduced AQP4 expression by 30% and was associated with 
significant decrements in edema formation, less BBB disruption, decreased astrogliosis, 
increased microglia activation, reduced neuronal cell death as well as improved 
neurological function during the acute phase after injury. We also observed that the 
siAQP4 treated animals had improved hippocampal neuronal cell count and memory 
recall at long-term: up to 60 days after injury as well. The uniqueness of our approach in 
implementing siRNA targeting AQP4 to improve functional outcomes after jTBI at both 
short and long-term after injury strongly suggests a potential future for clinical 
development. 
MRI (T2, ADC) was used to temporally monitor edema formation as is done 
clinically after brain injury(8, 18). Our MRI data showed less post-traumatic edema after 
siAQP4 treatment (Fig 2) as manifested by significantly reduced T2 values in siAQP4 
compared to siGLO-treated rat pups at 3d, suggesting less water accumulation within the 
lesion/perilesion and hippocampal tissues (Fig 2).  
Beneficial effects of siAQP4 on water mobility as reflected by reduced ADC 
values were also observed. ADC values are dramatically increased in the injury site and 
likely correspond to cell death leading to an altered tissue matrix. This increase in ADC 
at the lesion is decreased in siAQP4 compared to siGLO-treated rats, suggesting that 
siAQP4 mitigates cell death at this early time point but not at 3d (Fig 2). However, in 
adjacent tissues such as the hippocampus, the ADC values were also significantly 
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decreased, suggesting that siAQP4 may prevent cell death even at 3d in the hippocampus, 
by limiting edema expansion. This hypothesis is supported by the increased numbers of 
neurons in the siAQP4 treated animals at 3d (Fig 6). However, decreased ADC could also 
be associated with a decrease in AQP4 expression on the astrocyte endfeet (Fig 1) at 3d 
in accordance with our previous studies (14). In fact, decreased AQP4 expression has 
been correlated with decreased ADC (14, 19) and increased AQP4 expression has been 
correlated with increased ADC (20) in rats. This suggests that water diffusion is limited 
by the decrease of AQP4 in the siAQP4-treated pups (Fig. 1). Together, the MRI data 
demonstrate that siAQP4 treatment prevents edema formation with decreased T2 and 
ADC values in the lesion and ipsilateral hippocampus. At 3d, T2 values are significantly 
higher in the lesion/perilesion suggesting an increase in water content in the tissue due to 
ongoing vasogenic edema formation in the untreated animals; while the decrease in the 
siAQP4 treated rats suggest that siAQP4 prevents vasogenic edema formation. This 
hypothesis is supported by the evidence of less BBB disruption (decreased IgG 
extravasation, increased EBA and claudin-5 staining) in siAQP4 compared to siGLO 
treated animals. In fact, injection of siAQP4 after jTBI may prevent water entry into 
astrocytes and block subsequent swelling of these cells at 1d as indicated by the lower 
values of ADC in siAQP4 animals compared to siGLO. Less osmotic stress on the 
astrocytes may prevent BBB disruption by maintenance of the physical and mechanical 
properties of the endothelial cells and also neurovascular unit (Fig 3, 4). Therefore, less 
BBB disruption appears to be associated with less astrogliosis, which has been correlated 
with the severity of brain injury (21).  
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The next question was whether beneficial effects could still be observed at long-
term after injury, and whether there were significant down regulation of AQP4. This is an 
important question when considering the hypothesized biphasic and dual role that AQP4 
plays not only in edema formation but also in edema clearance and maintaining regular 
water homeostasis (22-23). It has been hypothesized and several experimental 
observations hint that the presence of AQP4 is detrimental acutely after injury because 
they contribute to the entry of water into the brain parenchyma so acute down regulation 
of AQP4 may be beneficial, but chronic AQP4 depletion may be detrimental as AQP4 is 
also needed for water clearance and maintenance of normal water homeostasis (24-27). 
To this end, we performed a Western blot at 60d and also performed 
immunohistochemistry to see if there were visible differences in AQP4 expression levels. 
At 60d, we observed no differences in AQP4 levels or staining, thus injection of siAQP4 
right after injury down-regulates AQP4 acutely but does not lead to chronic, long-term 
depletion of AQP4. This is another beneficial effect of using siRNA as it allows 
conditional down-regulation limited in the time of the target protein of interest.  
The beneficial effects of siAQP4 treatment were also observed in the higher 
number of neurons (NeuN positive cells) in siAQP4 compared to siGLO treated rats at 
both acute and long-term after injury. These improvements led to improved neurological 
outcomes at 1 and 3d in siAQP4 treated rats (Fig 7A, B). This improvement in motor 
function was not visible at 7d, which may be a natural recovery or loss of some neurons 
in perilesional cortex as shown at 60 days (Fig. 6). Interestingly, at 60d, there were a 
significantly higher number of NeuN positive cells in the CA1 region of siAQP4 
compared to siGLO; an effect of which can be observed in memory improvement. Our 
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unique data strongly suggest that the early decrease in AQP4 mitigates development of 
secondary injuries such as edema resulting in chronic neuroprotection for the perilesional 
structures, such as the hippocampus. 
siAQP4 treatment resulted in greater microglial activation around the injection 
site at 3d but not at 60d. Microglial activation after siAQP4 treatment is in accordance 
with previous observations in brain injury models using AQP4
-/-
 mice (28-29). However, 
acute microglial activation is hypothesized to be beneficial after injury (30), whereas a 
chronic microglial activation is hypothesized to be detrimental (30), so it is likely that at 
this time point, increased microglial activation due to siAQP4 treatment is contributing to 
the beneficial effects observed in our model. This observation suggests a potential 
relation between the level of AQP4 (Fig 1), astrogliosis and microglia activation (Fig 4, 
7G1-G2).  
We have previously speculated in a previous review (23) two of the possible 
mechanisms responsible the relationship between AQP4 and microglial activation. The 
first potential mechanism may be due to cross-talk that occurs between astrogliosis and 
microglial activation (31). It is possible that the decreased extent of injury-induced 
reactive astrogliosis is a result of knocking down AQP4 resulting in increased microglial 
activity. A second possible mechanism behind the changes observed in post-traumatic 
microglial activation in response to injection of siRNA against AQP4 may be because of 
the stretch-activated chloride channels expressed in microglia cells (32). Stretch-
activated; also known as swelling-activated chloride channels, are activated by osmotic 
stress (33). Activation of these stretch-activated chloride channels contributes to the 
maintenance of the non-activated (ramified) phenotype of microglia (32). Because AQP4 
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is responsible for water transport, down-regulation of AQP4 through siRNA could have 
decreased the osmotic stress on the microglia, thus limiting the activation of the swelling 
activated chloride channels, resulting in microglial activation.  
Both of these mechanisms are equally possible based on the data that we report, 
because at 3d, when both AQP4 levels and astrogliosis are decreased in the siAQP4 
treated rats, we observe an increase in microglial activation. However, at 60d, when 
AQP4 levels and extent of astrogliosis are not changed between the groups, no significant 
differences in microglial activation are observed. 
Our results are in accordance with studies using knockout animals showing that 
AQP4
-/-
 had improved outcomes compared to WT mice in cerebral pathologies such as 
hyponatremia (34), bacterial meningitis (34), water intoxication (25), focal cerebral 
ischemia (25), spinal cord injury (35), and encephalomyelitis (36). Thus, the importance 
of the development of an AQP4 inhibitor cannot be underestimated. However, as noted 
earlier no specific effective drug directly against AQP4 is now available (8), despite 
promising studies using agents such as bumetanide (11), acetazolamide (37-38) and 
methazolamide (38-39). Our study provides a novel therapeutic strategy to successfully 
target AQP4, leading to better outcomes after injury when edema is a prominent 
pathological feature. Our findings are unique, demonstrating proof of concept that 
siAQP4 treatment when given twice after injury reduces AQP4 expression by 30% and 
this is sufficient to achieve beneficial functional outcomes on edema formation as well as 
functional improvements, even long term after injury. Despite the relative modest 
changes of each individual measurement, the combined effect on the neurovascular unit 
is synergistic, with less neuronal cell death and functional improvements up to 60d post-
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jTBI. Furthermore, acute siAQP4 treatment does not lead to chronic or complete 
depletion of AQP4, which in itself could be detrimental to the recovery and overall health 
The next step would be to investigate the most efficient method to deliver an 
AQP4 inhibitor to the brain without craniotomy. One potential administration route 
would be intranasal delivery, which bypasses the BBB, is noninvasive, and easily 
performed (40). Our novel findings provide compelling evidence for the effectiveness of 
siAQP4 as a potential therapeutic agent not only for jTBI, but also for other brain 
disorders in which edema is a significant contributing factor. 
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Abstract 
Juvenile traumatic brain injury (jTBI) is the leading cause of death and disability 
for children and adolescents in the United States of America, but there is no 
pharmacological treatment after injury. Perivascular astrocytes and the astrocyte network 
is known to be affected by many brain pathologies and is hypothesized to be responsible 
for the secondary injury cascade, where cells and regions further from the actual site of 
injury are affected detrimentally. One such secondary injury pathway is blood brain 
barrier disruption and edema, for which several astrocyte proteins are highly likely to be 
responsible. We have previously published one of these key perivascular astrocyte 
proteins, aquaporin 4 (AQP4), to be increased after jTBI at multiple timepoints after 
injury and have shown that decrease of AQP4 expression with small interference RNA 
against AQP4 mitigates edema formation and the presence of reactive astrocytes after 
juvenile traumatic brain injury (jTBI). Due to the proximity of the AQP4 water channels 
and gap junctions and the possibility of water diffusion via gap junctions, the potential 
role of the astrocytic gap junction forming connexins were studied. In the first part of the 
experiment, changes in proteins involved in the formation of the astrocyte network gap 
junctions: Cx30 and Cx43, were evaluated after jTBI. In a second experiment, we 
evaluated the effect of small interference RNA against Cx43 on edema formation, 
reactive astrogliosis, and motor recovery. 
Cx proteins make up the gap junctions which connect neighboring astrocytes, 
allowing for the flow of ions, metabolites, neurotransmitters, and water. It has been 
speculated that these Cxs are responsible for the secondary injury cascade because of this 
flow from the primary injury site to distant sites, and AQP4 may be functionally coupled 
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to Cx43. We observed that Cx43 was increased at 3d, 7d, and 60d in the perilesional 
cortex, and Cx30 was increased at 1d and 3d. We also observed Cx43 to be increased at 
3d and 7d in the CA1 and Cx30 increased at 1d in the same region. Additionally, 
astrogliosis was increased after jTBI at 1d, 3d, 7d, and 60d as seen via GFAP analysis. 
siCx43 did result in improved motor recovery and decreased GFAP immunoreactivity but 
did not result in differences in edema formation as measured via T2 (water content) or 
ADC (water mobility) using MRI at 1d or 3d. From this, we can speculate that although 
decreasing Cx43 has beneficial roles, the protein may not be contributing to the initial 
edema formation phase after jTBI in our model. 
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Introduction 
In the US, the annual incidence of non-military related traumatic brain injury 
(TBI) is approximately 1.7 million, of which 327,000 are hospitalized and 52,000 die 
(Faul et al., 2010). Juvenile traumatic brain injury (jTBI), which is the leading cause of 
death and disability in children and adolescents (Faul et al., 2010), is of especially severe 
concern because the population group most affected (emergency department visit, 
hospitalization, and death) are those younger than five, followed by teenagers 15 – 19 
years old (Faul et al., 2010). The effect of jTBI is two-fold: primary injury and secondary 
injury. Primary injury results mainly from the direct and immediate biomechanical 
disruption of the brain tissue. Secondary injuries are the result of an indirect and more 
delayed molecular mechanism occurring at sites directly surrounding the impacted site 
and evolves toward regions at a distance from the initial impact site (Bauer and Fritz, 
2004). Primary injury can only be lessened by taking preemptive caution such as wearing 
helmets, so the goal of potential therapeutics is to lessen the damage caused by the 
secondary injury (Morales et al., 2005). Some of the major determiners for secondary 
injury cascade are blood brain barrier (BBB) disruption and edema and cellular swelling 
(Bauer and Fritz, 2004). However, no pharmacological treatments exist against this 
ruthless epidemic.  
Although various cell types such as neurons, oligodendrocytes, and endothelial 
cells swell after injury, astrocytes are the first cell types to swell, and the swelling lasts 
the longest; in fact, perivascular astrocyte endfeet can swell within minutes after injury 
(Grange-Messent and Bouchaud, 1994), and this swelling may spread from primary 
injury site to distant sites: thus being responsible for the secondary injury cascade. 
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Therefore the need to study the astroglial pathophysiology after jTBI is necessary to 
successfully target these injury cascades such as edema. We have previously published a 
study in which the expression level of aquaporin 4 (AQP4) - a key perivascular astrocyte 
endfeet protein responsible for water homeostasis under normal condition and the edema 
process after injury - was shown to increase at multiple timepoints after jTBI that 
coincided with both the peak of edema formation at 3d and edema resolution at 7d 
(Fukuda et al., 2012a), and early downregulation of this protein via small interference 
RNA after brain injury showed beneficial effects after jTBI both during the acute and 
chronic phase due to decreased edema (Fukuda et al., 2013).  
However, the aforementioned spread of secondary injury is not only due to the 
entrance of water from the peripheral blood stream to the brain parenchyma across 
AQP4, but most likely also due to the astrocyte network, which is mediated by gap 
junctions. Astrocytic gap junctions form the connection between neighboring astrocytes, 
allowing the flow of various molecules and water, and the proteins that make up these 
gap junctions are the connexins (Giaume et al., 2010). Six connexin proteins form a 
connexon, which is a hemichannel, and when a hemichannel from one cell attaches with 
another hemichannel of an adjacent cell, that is called a gap junction. Therefore, 12 
connexins make up one gap junction (Giaume et al., 2010).  The connexin subtypes are 
named according to their molecular weight, thus Cx43 has a molecular weight of 43 
kiloDalton and Cx30 has that of 30 kiloDalton. Of these connexins, Cx43, which is 
predominantly astrocytic (Giaume et al., 2010; Rash et al., 2001), is one of the most 
studied connexin in the brain and highly expressed in astrocytes, which far outnumber 
other cell types in the brain, including neurons (Sofroniew and Vinters, 2010). Connexin 
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43 form a hemichannel that has an aqueous pore and selectively permits flow of small 
endogenous molecules such as second messengers, amino acids, nucleotides, small 
peptides, and also water (Giaume et al., 2010; Goodenough and Paul, 2003; Herve and 
Derangeon, 2012; Wallraff et al., 2006). The hypothesized spread of detrimental factors 
and toxic metabolites such as sodium and calcium ions, apoptotic factors, 
lysophospholipids, cAMP, and IP3 from the primary injury site to more distant sites 
mediated by gap junctions is referred to as “bystander effect (Andrade-Rozental et al., 
2000; Perez Velazquez et al., 2003),” and several studies have shown astrocytic connexin 
levels to be increased in affected brain regions after cerebrovascular pathologies such as 
stroke (Chew et al., 2010). However, no study has been done to characterize the levels of 
the astroglial gap-junction forming connexins after jTBI. 
Several studies using general gap junction inhibitors such as carbenoxolone and 
octanol have shown better outcome in several ischemic stroke models (Andersson et al., 
2011; Frantseva et al., 2002; Perez Velazquez et al., 2006; Rawanduzy et al., 1997). Of 
note, Wu et al. have recently shown that injection of antisense-oligodeoxynucleotide 
against Cx43 (AS-ODN Cx43) into the lateral ventricle one hour prior to TBI in adult rats 
led to decreased edema (as measured via the wet-dry brain weight method) and decreased 
astrogliosis up to 48 hrs after injury compared to control group (Wu et al., 2013).  
But to date, there is no study done for a jTBI model in which Cx43 was specifically 
inhibited. We have previously shown small interference RNA against aquaporin 4, 
another astrocyte protein essential in the edema process after jTBI (Fukuda et al., 2012a), 
to be beneficial after injury (Fukuda et al., 2013). Therefore, in this study, the therapeutic 
potential of small interference RNA against Cx43 (siCx43) will be pursued after jTBI. 
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Methods to inhibit Cx43 specifically by targeting its mRNA have been effective in 
several in vitro models (Chew et al., 2010), and the use of siCx43 in vivo in a model of 
corneal endothelial injury have also shown beneficial results (Grupcheva et al., 2012). 
Thus, siCx43 would be a specific and effective method to downregulate Cx43 protein to 
study the functional behavior outcome after jTBI. Furthermore, edema, astrogliosis, and 
blood brain barrier (BBB) disruption will be studied because they are common 
pathophysiological targets of jTBI influenced by the astrocyte network (Fukuda et al., 
2013).  
 
Materials and Methods 
General Experimental Setup 
 Two groups of studies were planned and performed. The first groups of studies 
were constructed in order to examine the changes in the astrocyte network connexin 
proteins (Cx43, Cx30) and GFAP levels after juvenile traumatic brain injury. The second 
group of studies were constructed in order to examine the effect of small interference 
RNA against Cx43 (siCx43) injection after juvenile traumatic brain injury on astrocyte 
network connexin proteins (Cx43, Cx30), GFAP, blood brain barrier permeability (IgG), 
edema (ADC, T2), and behavior/motor activities. 
 
Animal Care 
All animal care and experiments were conducted according to the Guidelines for 
Care and Use of Experimental Animals approved by Loma Linda University. All 
protocols and procedures were in compliance with the U.S. Department of Health and 
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Human Services Guide and were approved by the Institutional Animal Care and Use 
Committee of Loma Linda University. Postnatal day 17 (P17) Sprague Dawly rat pups 
were housed in a temperature controlled (22-25
o
C) animal facility on a 12-hour light/dark 
cycle with standard lab chow and water ad libitum. 
 
siRNA Preparation 
An in vivo Cx43 silencing protocol was adapted as described in our previous 
studies.(Badaut et al., 2011) Briefly, SMART-pool® containing 4 siRNA-duplexes 
against Cx43 (400ng, siCx43, Dharmacon Research) and non-targeted siRNA (siGLO 
RISC-free-control-siRNA, Dharmacon Research) were mixed with interferin® (Polypus-
transfection, Illkirch, France) diluted in a saline solution (0.9%) containing 5% glucose 
for a final volume of 5 L and incubated on ice for 20 min before injection.  
 
Controlled Cortical Impact and siRNA Injection 
Controlled cortical impact (CCI) was carried out on P17 old rat pups as 
previously described (Ajao et al., 2012; Fukuda et al., 2012a; Fukuda et al., 2013). Rats 
were anesthetized with isoflurane and placed in a stereotaxic apparatus (David Kopf 
Instrument, Tujunga, USA). A 5 mm diameter craniotomy over the right hemisphere 3 
mm posterior from bregma and 4 mm lateral to midline was performed. Animals were 
subjected to CCI using an electromagnetic impactor with a 2.7 mm round tip set to 
impact with a velocity of 6 m/s and a depth of 1.5 mm below the cortical surface (Leica, 
Richmond, IL). Sham animals received the craniotomy, but without the cortical impact. 
The craniotomy did not cause damage to the dura mater and was intact in both the jTBI 
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and sham groups. After CCI, none of the animals had major bleeding or cortical tissue 
herniation.   
siRNA administration was performed as previously described (Fukuda et al., 
2013). Injection of siRNA was performed 10 min after the injury lateral to the site of the 
impact using a 30-gauge needle on a Hamilton syringe (3 mm posterior to bregma, 6 mm 
lateral to midline, and 1.0 mm below cortical surface). The syringe was attached to a 
nanoinjector (Leica, Richmond, IL) and 4 L of either siCx43 or siGLO was 
administered at a rate of 0.5 L/min. After suturing, all pups were placed on a warm 
heating pad for recovery before being returned to their dams. A second siRNA injection 
was repeated 2 days after the CCI in all pups that received siRNA using the same 
injection protocol. 
 
Magnetic Resonance Imaging (MRI) 
MRI was performed at 1 and 3d to follow the process of edema formation and to 
observe water content and water mobility at the peak of edema in this model (Fukuda et 
al., 2012a; Fukuda et al., 2013). Pups were lightly anesthetized using isoflurane (1.0%) 
and imaged on a Bruker Avance 11.7 T (Bruker Biospin, Billerica, MA)(Fukuda et al., 
2013)  Two imaging data sets were acquired: 1) a 10 echo T2- and 2) a diffusion 
weighted imaging (DWI) sequence in which each sequence collected 20 coronal slices (1 
mm thickness and interleaved by 1 mm). The 11.7T T2 sequence had the following 
parameters: TR/TE = 2357.9 / 10.2 ms, matrix = 128 x 128, field of view (FOV) = 2 cm, 
and 2 averages. The DWI sequence had the following parameters: TR/TE = 1096.5 / 50 
110 
ms, two b-values (116.960, 1044.422 s/mm
2
), matrix = 128 x 128, FOV = 2 cm, and 2 
averages.  
 
Region of Interest (ROI) and Volumetric Analysis 
T2 and apparent diffusion coefficient (ADC) values were quantified using 
previously published standard protocols (Badaut et al., 2011). Regions of interest (ROIs) 
were placed on the imaging section with the maximally detected injury using Cheshire 
(Parexel International Corp. Waltham, MA). Lesion and ipsilateral hippocampus were 
delineated on T2 images and overlaid onto corresponding T2 and ADC maps. The mean, 
standard deviation, and area for each ROI were extracted. 
 
Behavioral Testing 
Foot-fault and rotarod testing was performed at 1d and3d in both the siCx43 and 
Control group. The foot-fault test evaluated sensorimotor, coordination, and 
proprioception while the rotarod test evaluated sensorimotor coordination and balance as 
previously reported in our earlier studies.(Ajao et al., 2012) All tests at each time-point 
were carried out on siGLO and siCx43 treated rats within a 3-hours morning time-block 
(8 – 11 am). siGLO and siCx43 treated rats were interleaved in testing sequence. To 
further control potential confounds, the same tests were administered in the same order at 
all of the time points, by the same investigators blinded to the experimental groups. 
Foot-fault testing was carried out on an elevated platform (50 cm X 155 cm, 
ClosetMaid, Ocala, FL) with parallel wire bars 1.5 cm apart and raised 100 cm above the 
floor. Rats were placed in the middle of the platform to freely roam around. When a 
111 
rodent’s paw (fore- or hindlimb) slipped completely through the wire mesh, it was 
considered as an individual fault. The average foot-fault score was calculated from the 
total number of faults from two 60 sec trials.   
Rotarod evaluation was performed on all the animals at 1d and 3d (SD 
Instruments, San Diego, CA). A rotating 7 cm-wide spindle with a continuous speed 
(10RPM and 20 RPM) was used to evaluate performance during two trials per speed. 
Latency to fall was the outcome measure used as a measure of motor coordination and 
balance. The maximum time spent on the test was 60s, if the rat did not fall, at which 
point the rotation was halted and the rat was taken off of the spindle. The average time 
from the 2 trials was calculated and expressed in total time (s) for 2 trials. 
 
Immunohistochemistry and Image Analysis 
For the first set of experiments in which the connexin and GFAP expression was 
studied between animals who received CCI and sham group, at 1d, 3d, 7d, and 60d 
animals were transcardially perfused with 4% paraformaldehyde and brains were 
extracted and put in 30% sucrose for 48 hours, then stored in -22°C. Coronal sections 
were cut at 20 μm thickness at -22°C on a cryostat (Leica, Richmond, IL) and mounted 
on slides for immunohistochemical analysis (Badaut et al., 2007; Badaut et al., 2011; Hirt 
et al., 2009). For the second set of experiments in which siRNA was injected after jTBI, 
animals were transcardially perfused at 3d. 
The primary antibodies used for immunohistochemistry were rabbit polyclonal 
antibodies for Cx43 (1:100, Abcam, Cambridge, MA), rabbit polyclonal antibodies for 
Cx30 (1:100, Abcam, Cambridge, MA), and chicken polyclonal antibodies for GFAP 
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(1:1000, Millipore, Billerica, MA). The secondary antibodies used were IRDye 800 
conjugated affinity purified donkey-anti-rabbit IgG (1:1000, Rockland, Gilbertsville, 
PA), IRDye 680 conjugated affinity purified donkey-anti-chicken IgG (1:1000, Rockland, 
Gilbertsville, PA), Alexa 594 conjugated affinity purified goat anti-rabbit IgG (1:1000, 
Invitrogen, Carlsbad, CA), Alexa 488 conjugated affinity purified goat anti-rabbit IgG 
(1:1000, Invitrogen, Carlsbad, CA), Alexa 568 conjugated affinity purified goat anti-
chicken IgG (1:1000, Invitrogen, Carlsbad, CA), and Alexa 488 conjugated affinity 
purified goat anti-chicken IgG (1:1000, Invitrogen, Carlsbad, CA).  
For immunohistochemistry, sections were washed with PBS, blocked with 1% 
BSA in PBS, incubated with the respective primary antibodies in PBS containing 0.1% 
Triton X-100 and 1% bovine serum albumin overnight, then incubated for 2 hours at 
room temperature with affinity purified secondaries conjugated to the desired wavelength 
in PBS containing 0.1% Triton X-100 and 1% bovine serum albumin. After washing, 
sections were scanned on an infra-red (IR) scanner (Odyssey) to quantify fluorescence for 
the different ROIs as previously described (Badaut et al., 2011) or imaged under a 
confocal laser microscope (Zeiss). For sections to be imaged under a confocal 
microscope, sections on glass slides were cover-slipped with anti-fading medium 
VectaShield containing 4’,6-diamidino-2-phenylindole (DAPI) (Vector, Vector 
laboratories, Burlingame, CA, USA).  
All image acquisition parameters for the same proteins were kept constant for all 
of the animals for analysis and visualization purposes and all analysis was carried out in a 
non-biased, blinded manner. For the analysis of Cx43, Cx30, and GFAP, the following 
method was used as previously described (Fukuda et al., 2013). The slides with the above 
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mentioned primary antibodies with the secondaries conjugated to the infrared wavelength 
(680 or 800 nm) were scanned on an infrared scanner (Odyssey, Lincoln, NE), and 
images were saved with a resolution of 21 μm per pixel. Identical circular regions of 
interests (ROIs) were drawn in the perilesional cortex and in the ipsilateral CA1 at three 
different bregma levels (-1.40mm, -2.56mm, and -3.80mm): the bregma level where 
lesion area was largest, one slice anterior and one posterior. The average fluorescence of 
these regions of interests was calculated to show immunoreactivity of each of the protein 
and between groups.  
Negative control staining where the primary antibody or secondary antibody was 
omitted showed no detectable labelling. 
For immunoglobulin (IgG) extravasation immunohistochemistry, sections were 
washed with PBS, blocked with 1% BSA in PBS, then incubated for 2 hours at room 
temperature with IRDye 800 conjugated affinity purified goat-anti-rat IgG (1:500, 
Rockland, Gilbertsville, PA) in PBS containing 0.1% Triton X-100 and 1% bovine serum 
albumin. After washing, sections were scanned on an infra-red (IR) scanner (Odyssey) to 
quantify fluorescence for the different ROIs and also to measure the area of extravasation 
divided by the total brain area per ROI.  
 
Western Blot 
At 3d and 7d, the brains were freshly extracted from another set of sham and jTBI 
animals, the cortical tissue adjacent to the site of impact was collected and frozen for 
western blot analysis as previously published (Fukuda et al., 2012a). Tissues were placed 
in a tube with RIPA buffer with protease inhibitor cocktail (PIC, Roche, Basel, 
114 
Switzerland) and sonicated for 30s and stored in -20C. These samples were then assayed 
for total protein concentration by bicinchoninic acid assay (BCA, Pierce Biotechnology 
Inc., Rockford, IL). Ten micrograms of protein was then subjected to SDS 
polyacrylamide gel electrophoresis on a 4–12% gel (Nupage, Invitrogen, Carlsbad, CA, 
USA). Proteins were then transferred to a polyvinylidene fluoride membrane 
(PerkinElmer, Germany). The blot was incubated with a rabbit polyclonal antibody 
against Cx43 (1:1000, Abcam, Cambridge, MA) or Cx30 (1:1000, Abcam, Cambridge, 
MA) and a monoclonal antibody against tubulin (Sigma, Switzerland, 1:25,000) in 
Odyssey blocking buffer (LI-COR, Bioscience, Germany) for 2 h at room temperature. 
After washing in PBS for 3x10min, the blot was incubated with two fluorescence-
coupled secondary antibodies (1:10,000, anti-rabbit Alexa-Fluor-680 nm, Molecular 
Probes, Oregon and anti-mouse infra-red-Dye-800-nm, Roche, Germany) for 2 h at room 
temperature. After washing in PBS, the degree of fluorescence was measured using an 
infra-red scanner (Odyssey, LI-COR, Germany) as previously published (Fukuda et al., 
2013). The value of Cx43 and Cx30 was normalized to tubulin and compared between 
jTBI and sham at each timepoint. 
 
Statistics 
 One way ANOVA was used for immunohistochemistry analysis and western blot 
to compare the mean between the sham and jTBI group at each timepoint. One way 
ANOVA was used for immunohistochemistry analysis to compare the mean between 
siGLO and siCx43 group as well. Two-way repeated measures analysis of variance with a 
115 
post hoc Bonferroni test was used for the behavior and MRI data. A p value less than 
0.05 was considered to be statistically significant.  
 
Results 
Chronic Increase of Connexin 43 Expression after jTBI 
 
Cx43 protein changes were first evaluated using infra-red immunohistochemistry 
at 1d, 3d, 7d and 60d post-jTBI. At 1d, there was no significant difference (Fig. 1A). 
However, during the edema period from 3d to 7d in this model (Fukuda et al., 2012b), 
increase in the level of Cx43 immunofluorescence at 3d and 7d compared to age-matched 
sham operated animals in the perilesional cortex was observed (Fig. 1A, p<0.05). 
Furthermore, the increase of the Cx43 immunoreactivity was still observed up to 60d, 
suggesting a signature involvement of the reactive astrocytes. Similar increase at 3d was 
observed (p<0.05) in ipsilateral hippocampus located under the site of the impact, when 
compared to age-matched sham operated animals (Fig. 1B). However, after 3d there were 
no significant changes in Cx43 in the hippocampus. No differences were observed 
between groups in the contralateral cortex and hippocampus. 
The immunohistochemistry data was confirmed by western blot analysis for the 
time points 3 (Fig. 1C) and 7days (Fig. 1D). Cx43 western blot showed an expected band 
at 43 kda in both groups, with a higher intensity for the jTBI group compared to sham 
animals. The level of intensity of Cx43 was normalized to beta-tubulin, used as a 
housekeeping protein (Fig. 1C-F). The quantification of the band showed a significant 
increase for the two time points, with 30% increase at 3d (Fig. 1E) and 200% increase at 
7d (Fig. 1F). 
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Figure 1. Chronic increase of Connexin 43 expression after jTBI. (A) Cx43 staining 
quantification in the perilesional cortex showed increased Cx43 immunoreactivity at 3d, 
7d, and 60d after jTBI as compared to sham. (B) Cx43 immunoreactivity in the ipsilateral 
hippocampus showed a significant increase at 3d (*p<0.05). Western blot of Cx43 at 3d 
(C) and 7d (C) shows a distinct band of Cx43 at around 43kDa. jTBI shows a 
significantly higher expression of Cx43 at both 3d (E) and 7d (F) compared to sham. 
(Cx43, connexin 43; kDa, kilo Dalton; jTBI, juvenile traumatic brain injury; *p<0.05). 
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Connexin 30 is Upregulated Acutely after jTBI 
Cx30 protein changes were first evaluated using infra-red immunohistochemistry 
at 1d, 3d, 7d and 60d post-jTBI. At 1d and 3d, a significant increase was observed in 
immunoreactivity in the perilesional cortex in the injured animals compared to age-
matched sham operated control animals (Fig. 2A, p<0.05). However, no significant 
difference was observed in the perilesional cortex at 7d and 60d. In the ipsilateral 
hippocampus located under the site of the impact, a significant increase in Cx30 
immunoreactivity was observed at 1d (p<0.05) when compared to age-matched sham 
operated animals but not at the other timepoints (Fig. 2B).  
The immunohistochemistry data was confirmed by western blot analysis for the 
time points 3 (Fig. 2C) and 7days (Fig. 2D). Cx30 western blot showed an expected band 
at 30 kDa in both groups, with a higher intensity for the jTBI group compared to sham 
animals at 3d. The level of intensity of Cx43 was normalized to beta-tubulin, used as a 
housekeeping protein (Fig. 2C-F). The quantification of the band showed a 200% 
increase at 3d (Fig. 2E, p<0.05), but no significant difference at 7d (Fig. 2F). 
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Figure 2. Connexin 30 is upregulated acutely after jTBI. (A) Cx30 staining quantification 
in the perilesional cortex showed increased Cx30 immunoreactivity at 1d and 3d after 
jTBI as compared to sham. (B) Cx30 immunoreactivity in the ipsilateral hippocampus 
showed a significant increase at 1d (*p<0.05). Western blot of Cx30 at 3d (C) and 7d (C) 
shows a distinct band of Cx30 at around 30kDa. jTBI shows a significantly higher 
expression of Cx30 at 3d (E) but not at 7d (F) compared to sham. (Cx30, connexin 30; 
kDa, kilo Dalton; jTBI, juvenile traumatic brain injury; *p<0.05). 
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Astrogliosis Occurs and is Maintained after jTBI. 
The extent of astrogliosis was studied via glial fibrillary astrocytic protein 
(GFAP)-immunoreactivity (Fig. 3). GFAP is found in the astrocyte cytoskeleton and 
routinely used for studying astrocytes. GFAP staining intensity was increased in the 
perilesional cortex in jTBI induced rat pups compared to the age-matched control group 
at 1d, 3d, 7d, and 60d (Fig. 3A). Unlike the perilesional cortex in which a significant 
increase in astrogliosis was observed at all timepoints tested, in the ipsilateral 
hippocampus, a significant increase (p<0.05) was only observed at 1d (Fig. 6C).  
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Figure 3. Astrogliosis occurs and is maintained after jTBI. (A) GFAP staining 
quantification in the perilesional cortex showed increased GFAP immunoreactivity at 1d, 
3d, 7d, and 60d after jTBI as compared to sham. (B) GFAP immunoreactivity in the 
ipsilateral hippocampus showed a significant increase at 1d (*p<0.05). (GFAP, glial 
fibrillary acidic protein; jTBI, juvenile traumatic brain injury; *p<0.05). 
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siCx43 Injection Reduces Cx43 Expression 
Acutely after Injury 
 
Once the normal pathological change of astrocyte connexin was studied using 
jTBI and sham control animals, the next step was to test the effect of decreasing this 
protein. Because Cx43 expression after injury has been studied more extensively and thus 
far has been proposed to play a more central role in pathophysiological cascades after 
injury (Chew et al., 2010; Grupcheva et al., 2012; Nakase et al., 2004; Ohsumi et al., 
2010; Theodoric et al., 2012; Wu et al., 2013; Yoon et al., 2010), for our study Cx43 was 
chosen as the potential target. For this purpose, siRNA against Cx43 (siCx43) was 
injected in the lesion site after injury. To see if siCx43 was effective in decreasing Cx43 
expression, Cx43 protein changes were evaluated using infra-red immunohistochemistry 
at 3d post-jTBI. Injection of siCx43 induced a significantly lower level of Cx43 
compared to siGLO control group 3d after the injury (19% decrease) in the perilesional 
cortex (Fig. 4A), but no significant difference was observed in the ipsilateral 
hippocampus (Fig. 4B). 
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Figure 4. siCx43 Injection Reduces Cx43 Expression Acutely after Injury. Cx43 
immunoreactivity was quantified and confirmed a significant decrease in Cx43-
immunoreactivity in the siCx43 compared to siGLO treated rats in the (A) perilesional 
cortex but not in the (B) ipsilateral hippocampus (*, p<0.05). (Cx43; connexin 43). 
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siCx43 Injections did not Result in Changes in 
Cx30 Expression Acutely after Injury 
 
To test whether siCx43 injection had any acute effect on Cx30 expression due to 
either off targets effects or a compensatory mechanism, Cx30 protein changes were 
evaluated using infra-red immunohistochemistry at 3d post-jTBI as well. Injection of 
siCx43 did not result in a significant Cx30 immunoreactivity changes compared to siGLO 
control group 3d after the injury in neither the perilesional cortex (Fig. 5A) nor the 
ipsilateral hippocampus (Fig. 5B). 
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Figure 5. siCx43 Injections did not Result in Changes in Cx30 Expression Acutely after 
Injury. Cx30 immunoreactivity was quantified and showed no significant decrease in 
Cx30-immunoreactivity in the siCx43 compared to siGLO treated rats in both the (A) 
perilesional cortex and (B) ipsilateral hippocampus. (Cx30; connexin 30). 
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siCx43 Injection Resulted in Improved 
Behavior Outcome after jTBI 
 
To test whether Cx43 downregulation resulting from siCx43 injection had a 
beneficial effect regarding motor function recovery after injury, foot-fault and rotarod 
testing was performed at 1d and 3d. The foot-fault test evaluated sensorimotor, 
coordination and proprioception while the rotarod test evaluated sensorimotor 
coordination and balance. siCx43 pups had fewer foot-faults at 1 and 3d (respectively 
24% and 36%, p < 0.05, Fig 6A). Although a trend was observed in which siCx43 
animals were staying on the rotarod longer than siGLO control animals, the difference 
was not statistically significant (Fig. 6B). 
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Figure 6. siCx43 Injection Resulted in Improved Behavior Outcome after jTBI. siCx43-
treated pups had better functional outcomes as revealed by the foot-fault test. siCx43 
group had significantly fewer foot faults than siGLO treated animals at day 1 (24%) and 
day 3 (36%) after jTBI (*, p < 0.05) (A).  However, siCx43 animals’ performance on the 
rotarod did not significantly differ with that of siGLO at neither 1d nor 3d (B).   
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siCx43 Animals had Reduced Astrogliosis after jTBI 
 
Transgenic mice with Cx43 knocked out was associated with a decreased GFAP 
expression (Nakase et al., 2003) and Cx43 blockade has been shown to decrease GFAP 
immunoreactivity after injury (Wu et al., 2013). To study whether this was still valid in 
our model of jTBI, GFAP-infrared immunohistochemistry was used to assess the effects 
of siCx43 on neuroinflammation /astrogliosis after jTBI. There was a 17% decrease in 
GFAP immunofluorescence in the perilesional cortex of the siCx43 rat pups as compared 
to the siGLO control group (p<0.05, Fig. 7A). However, no significant difference was 
observed in the ipsilateral hippocampus (Fig. 7B).  
Because astroglial connexins have been hypothesized to play a role in BBB 
permeability (Ezan et al., 2012) and BBB disruption is a major pathophysiology after 
jTBI, the BBB permeability was assessed via immunoglobulin G (IgG) 
immunohistochemistry. Under normal circumstance IgG is not observed in the brain, 
however IgG is observed after injury in which the BBB is disrupted because IgG is 
extravasated from the peripheral bloodstream into brain tissue. IgG extravasation was 
calculated as the percentage of the area of IgG staining to total brain slice area. At 3d, 
there was no significant difference in the extent of IgG extravasation between siCx43 
(18.92%) and siGLO control (18.40%) (Fig. 7C), signifying no difference in the extent of 
BBB permeability between treated and untreated animals. 
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Figure 7. siCx43 animals had reduced astrogliosis after jTBI. GFAP staining 
quantification in the (A) perilesional cortex showed significant decrease in siCx43 
compared to siGLO animals but not in (B) the ipsilateral hippocampus. (C) The extent of 
IgG extravasation was not significantly different between siGLO and siCx43 animals, 
signifying most likely the same extent of BBB disruption/permeability (*p<0.05). 
(GFAP, glial fibrillary acidic protein; jTBI, juvenile traumatic brain injury; IgG, 
Immunoglobulin G; *p<0.05). 
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Significant Difference in T2 and ADC was not Observed 
Acutely between siCx43 and Control 
 
To address the question of whether decreased Cx43 protein level via siCx43 
injection would alter edema formation, MRI was utilized to obtain T2 and ADC values at 
1d and 3d. T2 was chosen as a measurement of edema/water content and ADC was used 
as a measurement of water mobility. T2 and ADC values were analyzed in the 
perilesional cortex and ipsilateral hippocampus at 1d and 3d in all of the animals from the 
siCx43 and siGLO groups. In the perilesional cortex, there was no significant difference 
in T2 values between siGLO (1d – 116.58 +/- 6.82 ms; 3d – 93.54 +/- 3.47 ms) and 
siCx43 (1d – 107.75 +/- 7.85 ms; 3d- 101.27 +/- 7.86 ms) (Fig. 8A). Similarly, in the 
ipsilateral hippocampus, no significant difference was observed between siGLO (1d - 
121.53 +/- 7.45 ms; 3d - 99.29 +/- 3.01 ms) and siCx43 (1d – 114.66 +/- 8.47 ms; 3d – 
109.45 +/- 7.45ms) (Fig. 8B). 
 For ADC values in the perilesional cortex, no significant difference was observed 
between siGLO (1d – 720.25 +/- 69.01 x10-6mm2/sec; 3d – 690.11 +/- 57.56 x10-
6
mm
2
/sec) and siCx43 (1d – 763.56 +/- 38.25 x10-6mm2/sec; 3d – 766.65 +/- 61.93 x10-
6
mm
2
/sec) (Fig. 8C). No significant difference was observed in the ipsilateral 
hippocampus either between siGLO (1d – 708.02 +/- 62.70 x10-6mm2/sec; 3d – 703.98 
+/- 70.18 x10
-6
mm
2
/sec) and siCx43 (1d – 769.96 +/- 59.07 x10-6mm2/sec; 3d – 815.10 
+/- 91.68 x10
-6
mm
2
/sec) (Fig. 8D). 
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Figure 8. Significant difference in T2 and ADC was not Observed Acutely between 
siCx43 and Control. The extent of edema formation was assessed via MRI using T2 
(water content) and ADC (water mobility). The T2 value did not significantly differ 
between siCx43 and siGLO pups within the (A) perilesional cortex or (B) ipsilateral 
hippocampus at neither 1d nor 3d (B). The ADC value did not significantly differ 
between siCx43 and siGLO pups within the (C) perilesional cortex or (D) ipsilateral 
hippocampus at neither 1d nor 3d. This most likely signifies that siCx43 did not result in 
changes in the edema formation after jTBI. 
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Discussion 
Our novel study is the first to characterize the changes in Cx43 and Cx30 proteins 
after jTBI and also to assess the effect of a post injury administration of siCx43 in a 
model of jTBI during the acute period.  
Cx30 and Cx43 were increased in the perilesional cortex and ipsilateral CA1 after 
jTBI, although in a different pattern. GFAP was also used to assess the extent of 
astrogliosis after jTBI, and was observed to be increased after jTBI as well.  
siCx43 treatment after jTBI resulted in an improved neurobehavioral outcome and 
decreased reactive astrogliosis, resulting from a decreased Cx43 level. To the best of our 
knowledge, this is the first study to use neurobehavioral test as an outcome assessor after 
specific inhibition of Cx43 in a TBI model. 
 
Changes Seen in Astrocytic Connexins after jTBI 
Astrocytes form a network in which individual astrocytes connect with each other, 
allow neurotransmitter and ionic flow, and influence each other and the network as a 
whole. Appropriately, the term, astrocyte network (Giaume et al., 2010) is frequently 
used to describe this characteristic in which astrocytes are interconnected with each other 
through gap junctions that are made of connexin proteins: predominantly connexin 43, 
and also connexin 30, that facilitate intercellular communication (Giaume et al., 2010; 
Seifert et al., 2006). Despite this interest, there is yet much more to be studied for the 
ultimate goal of finding therapeutics for those suffering from presently untreatable or 
incurable cerebral dysfunctions. Astrocytes and the network they form are essential for 
normal brain function, and disruption of this network due to traumatic brain injury leads 
132 
to pathological cascades such as excitotoxicity, apoptosis, neuroinflammation, and edema 
(Fukuda et al., 2012a; Kimelberg, 2005; Woodcock and Morganti-Kossmann, 2013; 
Zhang et al., 2006). In the brain, the main astrocytic gap junction forming proteins are 
connexin 43 and connexin 30 (Nagy et al., 2004).  
Although Cx43 and Cx30 are both the main astrocytic connexin proteins, 
especially in the perivascular endfeet, the pattern of change was different between the 
two proteins, where Cx30 was acutely increased after injury but Cx43 was decreased 
initially, and upregulated chronically afterwards. In terms of edema, it is interesting to 
note that Cx30 is increased but Cx43 is not during the edema formation phase (1d), both 
Cx30 and Cx43 is increased during the peak of edema (3d) and only Cx43 is increased 
during the edema resorption phase (7d). In a model of stab wound injury, Cx43 showed 
an increase after injury but Cx30 did not (Theodoric et al., 2012). A model of neonatal 
cerebral hypoxia ischemia injury also showed different changes in expression pattern of 
the two proteins, in which Cx30 showed a slight increase acutely then normalized, 
whereas Cx43 protein levels did not change after injury (Zeinieh et al., 2010).  
Thus, acutely, the expression profile of Cx43 follows that of AQP4 as we 
previously described (Fukuda et al., 2012a), where a slight initial decrease, although not 
significant, at 1d is observed, followed by an increase at 3d and 7d (Fig 1). However, 
Cx43 was observed to still be increased even at 60d, whereas AQP4 was not. In contrast 
there is increased Cx30 levels starting from 1d, and maintained up to 3d (Fig 3), but not 
until 7d. This might signify that AQP4 and Cx43 may have a functional role together 
during the acute period. Accordingly, in astrocyte cell cultures, AQP4 downregulation led 
to decreased expression of Cx43 (Nicchia et al., 2005), and in a transgenic mice lacking 
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Cx43 and Cx30, decreased expression of AQP4 was observed (Ezan et al., 2012). Thus, 
Cx43 follows the pattern of AQP4, and may be contributing to the edema resorption at 7d 
after injury as speculated previously (Fukuda et al., 2012b). 
Increased connexins after injury has been proposed to be detrimental in several 
studies (Chew et al., 2010), but some have speculated connexins to be beneficial as well 
and there is no universal consensus (Andrade-Rozental et al., 2000; Farahani et al., 2005; 
Perez Velazquez et al., 2003). In adult models of TBI using a lateral fluid percussion 
injury model in adult rats, a similar pattern of Cx43 immunoreactivity was seen as our 
model of jTBI in which an initial reduction was followed by an increase in the 
hippocampus and the cortex (Ohsumi et al., 2006). However, it is interesting to note that 
this acute reduction was observed at 6h, and the immunoreactivity started to increase at 
24 hours (Ohsumi et al., 2006). This apparent shift of the time course of events may be 
due to a different injury model and/or different age, highlighting the importance of 
treating jTBI as a different pathology than adult TBI (Giza et al., 2007; Kochanek, 2006). 
Thus, it is most likely that the determining factors of whether connexin overexpression is 
beneficial or detrimental are the injury type and the timepoint after injury. Indeed it is 
possible that the connexins may have different functional roles during the acute and 
chronic phase after injury. And it is possible that the increased level of Cx43 could be 
beneficial during certain timepoints but not at others; as hypothesized for AQP4 where 
inhibition of AQP4 would be beneficial during the edema formation phase, but not during 
the edema resolution phase (Fukuda et al., 2012a; Fukuda et al., 2013). 
We hypothesized that astrocytes most likely play a multi-faceted role in the 
edema process because of Cx43 and AQP4. First, via a key protein expressed in the 
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perivascular astrocyte endfeet, aquaporin 4 (AQP4), a member of the water channel 
proteins expressed abundantly in the brain that permit water entry into the brain across 
the BBB. Second, through the astrocyte network, which facilitates intercellular 
communication through gap junction channels formed mainly by connexin 43 (Cx43) 
proteins, allowing the spread of water accumulation from the primary injured astrocytes 
to surrounding cells, causing them to swell as well. Furthermore, non-gap junction 
forming hemichannels may have an additional effect via excitotoxicity through 
extracellular signaling of ATP and glutamate (Bennett et al., 2012; Kar et al., 2012). 
In order to test the hypothesis of whether decreasing Cx43 after jTBI would result 
in decreased edema leading to improved recovery, we injected siCx43 after jTBI to assess 
the effect. 
 
The Effect of siCx43 Injection after jTBI 
We observed a decrease in GFAP immunoreactivity after siCx43 injection after 
jTBI (Fig. 7). This decrease in GFAP is in accordance with the aforementioned adult TBI 
study with the AS-ODN pretreatment (Wu et al., 2013) and another study in which gap 
junction inhibitors, carbenoxolone and octanol, was administered in adult rats that 
underwent a needle stab wound to mimic brain injury (Andersson et al., 2011). Although 
the exact function and implication of changes in GFAP immunoreactivity is debated, it is 
commonly regarded to be associated with reactive astrogliosis (Kimelberg, 2005; 
Sofroniew, 2009; Sofroniew and Vinters, 2010). Some evidences suggest that reactive 
astrogliosis may contribute to worsened secondary injury depending on the timepoint and 
injury model (Laird et al., 2008). In order to study the edema process, magnetic 
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resonance imaging (MRI) was used. Because diffusion weighted imaging (DWI) and T2-
weighted imaging is routinely used as a measure of edema in clinics (Chastain et al., 
2009; Galloway et al., 2008; Hou et al., 2007), and we routinely use it in juvenile animals 
(Badaut et al., 2007; Badaut et al., 2011; Fukuda et al., 2012a; Fukuda et al., 2013), it was 
used to map out the time course of the evolution of edema. Apparent diffusion coefficient 
(ADC) is a DWI parameter which can be thought of as a measure of cerebral water 
mobility and T2 can be thought of as cerebral water content. In a previous study using 
siAQP4, both ADC and T2 were decreased in jTBI animals injected with siAQP4, 
signifying decreased edema, which was associated with improved behavior outcome and 
decreased reactive astrogliosis (Fukuda et al., 2013). Thus it was hypothesized that the 
inhibition of edema and suppression of secondary injury spread by limiting water 
diffusion through the astroglial network as a whole could be achieved by either blocking 
water channels (astrocyte-BBB) or gap junctions (astrocyte-astrocyte communication). 
However, contrary to our initial hypothesis, post-injury administration of siCx43 did not 
result in a significant decrease in edema or BBB disruption.  
  There are several possible explanations for this observation. First, there is a 
possibility that both Cx43 and Cx30 (another astrocytic connexin) must be knocked down 
in order to decrease edema. Indeed, it is very plausible that water is still being propagated 
across the astrocyte network from the primary injury site to secondary injury sites 
through Cx30, compensating for the downregulated Cx43 channels; leading to no 
significant observable difference in water content or mobility. Second, pre-treatment/pre-
conditioning seems to yield a greater difference between treatment and control group, as 
seen in two studies which showed that pre-treating the animals with a gap junction 
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inhibitor resulted in a larger difference between the control than post-treatment 
(Andersson et al., 2011; Perez Velazquez et al., 2006). Thus, AS-ODN Cx43 may have 
resulted in decreased edema due to the pre-injury injection of the drug. Third, Cx43 in 
juvenile animals may not be a key player for the edema process. Water propagation or 
clearance may be a function that is more central to other astrocytic proteins, namely the 
AQP4 (Badaut et al., 2011). And it is entirely possible that a combination of the above 
given explanations may be true. Indeed, a conditional double knockout mice of astrocytic 
Cx43 and Cx30 was shown to have weaker BBB and astrocyte endfeet swelling (Ezan et 
al., 2012). Also in a model of global ischemia on sheep, Cx43 inhibition through a 
specific mimetic peptide was shown to result in increased neuronal and oligodendrocyte 
cell count if the peptide was given after the ischemia, but not before and during ischemia 
(Davidson et al., 2013).  
Although TBI studies on astrocytic Cx43 is sparse, increased Cx43 has been 
associated with post-injuries in other brain pathology as well (Chew et al., 2010). 
Furthermore, studies of other cerebropathologies such as ischemic stroke have reported 
beneficial results from the specific inhibition of Cx43 in vitro (Chew et al., 2010), and 
general gap junction inhibition in vivo (Andersson et al., 2011; Perez Velazquez et al., 
2006; Rawanduzy et al., 1997). This may be due to the inhibition of a proposed 
phenomenon known as the “bystander effect.” The bystander effect refers to the 
hypothesized spread of detrimental factors and toxic metabolites such as sodium and 
calcium ions, apoptotic factors, lysophospholipids, cAMP, and IP3 from the primary 
injury site to more distant sites mediated by gap junctions connecting the astrocyte 
network (Andrade-Rozental et al., 2000; Cronin et al., 2008; Grange-Messent and 
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Bouchaud, 1994; Perez Velazquez et al., 2003). Thus, siCx43 may be a unique and useful 
new technical approach to study the in vivo Cx43 involvement as well as a potential 
therapeutic tool in other brain injury models as well. However, it is interesting to note 
that in models of cerebral hemorrhage, detrimental effects for general gap junction 
inhibitors such as carbenoxolone and octanol have been reported: intracerebral 
hemorrhage (Manaenko et al., 2009) and experimental subarachnoid hemorrhage (Ayer et 
al., 2010). As proposed by the authors, these brain hemorrhages may follow a different 
pathway than TBI and stroke – namely that the detrimental factors are extracellular, and 
the intra-astrocellular bridges formed by gap junctions may not be as important (Ayer et 
al., 2010). 
In conclusion, we show here for the first time the temporal changes in Cx43, 
Cx30, and GFAP after jTBI. We also show that siCx43 injection after injury on juvenile 
animal results in improved sensorimotor, coordination, and balance recovery, associated 
with decreased Cx43 and reactive astrogliosis, but is not associated with the edema 
formation process. Future studies could further examine the affected pathways underlying 
the beneficial effects such as decreased cell death, neuroinflammation, or decreased 
excitotoxicity. 
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CHAPTER FIVE 
DISCUSSION 
 Parts of the following work has been published in the peer reviewed journal, 
Biochimica et Biophysica Acta, 2014 May;1840(5):1554-65.  
 
Aquaporin and Brain Diseases 
Edema Process: Role of the Aquaporins 
 Most brain diseases (e.g. stroke, traumatic brain injury, brain tumors, brain 
inflammation) present the hallmark of edema, which is water accumulation resulting from 
brain osmotic homeostasis dysfunctions. The main consequence of edema is the swelling 
of the brain, which aggravates the secondary injuries such as decrease of brain perfusion. 
Edema has been known in the clinic and pre-clinical science for many years but the 
molecular and cellular events in edema formation/resolution are still poorly understood. 
Moreover, there is no efficient treatment to prevent or limit edema formation or 
expansion in brain disorders. Thus, the discovery of the brain AQPs was a beacon of 
hope in the development of new therapy to battle the edema process. The knowledge 
gathered in the past 15 years on AQPs as a potential drug target for edema is summarized 
in the following parts after a short introduction on the edema build-up phase. 
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Edema Build-Up Phase: Anoxic, Ionic 
and Vasogenic Edema 
 
For 40 years, cerebral edema has been traditionally divided into 2 major classes: 
cytotoxic and vasogenic (Badaut et al., 2011b). Classically, cytotoxic edema is defined by 
intracellular water accumulation without blood-brain barrier (BBB) disruption while 
vasogenic edema appears after BBB disruption, leading to a diffusion of proteins from 
the blood to the tissue followed by water accumulation in the extracellular space (Badaut 
et al., 2011b). However, this classical subdivision has been challenged by the recent 
knowledge in molecular changes during the edema formation and BBB properties, and 
the classical subdivision represents a simplified view of a more complex pathological 
process. In regard to vascular brain injuries such as jTBI, the recent cellular and 
molecular events behind edema suggest that the edema build-up phase can be divided 
into 3 major types: anoxic, ionic and vasogenic edema (Simard et al., 2007, Badaut et al., 
2011b, Berezowski et al., 2012). Anoxic edema is characterized as swelling of the 
astrocytes and neuronal dendrites that occur within minutes (figure 1B) after oxygen and 
glucose deprivation in the context of cerebrovascular disease. The depletion of oxygen 
and energy nutrients induces major changes in the cellular ionic gradients due to the 
absence of efficient energy dependent co-transporters. This leads to a massive entry of 
ions into cells which can be observed in phenomenon such as a slow rise in extracellular 
K
+
 concentration (Milner and Campbell, 2002, Dityatev and Schachner, 2003), followed 
by water entry into the cells, which induces cellular swelling in astrocytes first, and then 
in neuronal dendrites (Figure 1B). Then, anoxic edema quickly evolves to become ionic 
edema. The absence of oxygen and nutrients also alters the ionic gradients of endothelial 
cells, including transcapillary flux of Na
+
 (O'Donnell et al., 2004, Simard et al., 2007) 
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with tissue swelling (Figure 1B). Suffering of endothelial cells therefore results in early 
transient leakage of the BBB in stroke (de Castro Ribeiro et al., 2006, Hirt et al., 2009) as 
well as in TBI (Pop et al., 2013). This results in further entry of water through endothelial 
cells leading to brain swelling as observed from examples in stroke models within 30 
minutes after reperfusion (de Castro Ribeiro et al., 2006, Hirt et al., 2009) associated with 
further increased BBB permeability (Strbian et al., 2008, Hirt et al., 2009). Vasogenic 
edema follows this cascade of events (Figure 1B) with increased permeability to plasma 
proteins such as albumin (Badaut et al.) due to a physical disruption of endothelial tight 
junctions, an extracellular matrix degradation and potentially an increased 
transendothelial cell transport by the transcytosis mechanism. 
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Figure 1. Disorganization of AQP4 in orthogonal particles after brain injuries and edema 
process. (A) AQP4-m1 (purple circles) and AQP4-m23 (blue circles) isoforms contribute 
together to form orthogonal array particles (OAPs) in astrocyte endfeet in contact to the 
blood vessels. It was previously shown that higher expression of AQP4-m23 contributes 
to the formation of large OAPs. However, increase of AQP4-m1 induced disruption of 
OAPs with a reduction of the size. This modification is observed in pathological 
conditions such as stroke. Recent knowledge on AQP leads us to hypothesize that the 
large OAPs contribute to gas and cation diffusion in the astrocyte membranes through 
central pores (green arrows) (modified from [33]). (B) Schematic drawing of the events 
happening during edema formation with 3 different edema phases: anoxic, ionic and 
vasogenic edema. During the injury with decrease of brain perfusion, the first minutes are 
characterized by anoxic edema. Anoxic edema is characterized as a swelling of the 
astrocytes and the neuronal dendrites caused by a disruption of the cellular ionic 
gradients and the entry of ions followed by water entry and leading to cellular swelling.  
During the ionic edema, astrocytes become swollen and neuronal death starts to occur 
resulting in shrinkage of the neurons, shear stress and endothelial dysfunctions on the 
non-perfused vascular tree, which results in early transient leakage of the BBB. 
Vasogenic edema is a result of disruption of the tight junctions between the endothelial 
cells, leading to increased permeability of the cerebral blood-vessels to albumin and other 
plasma proteins, further contributing to swelling of astrocytes and subsequent neuronal 
cell death. (adapted from [33]). 
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It is important to mention that this definition was proposed in the context of brain 
injuries involving acute cerebrovascular dysfunctions and may not be adequately adapted 
for other brain disorders such as brain tumors (Nico and Ribatti, 2011). In this regard, it 
is important to underline that clinical treatments solely focusing on osmotic challenges 
are not efficient or sufficient for treatment of cerebral edema, because of the suggested 
complexity and diversity in the molecular mechanisms underlying the edema formation 
process. Although the exact functional contributions of cerebral AQPs are not yet fully 
understood, because of their localization and their identity as water channel proteins, they 
most likely play vital roles in the cerebral edema process. We will now review the role of 
the AQPs within the context of this revised subdivision of edema formation. 
  
AQP4 and Edema Build-Up 
Acute brain injuries including trauma (Ke et al., 2001, Fukuda et al., 2012), 
ischemia (Meng et al., 2004, de Castro Ribeiro et al., 2006), and subarachnoid 
hemorrhage (Badaut et al., 2003), each have distinct patterns of alteration in the level of 
AQP4 expression. Early after stroke, AQP4 expression is rapidly up-regulated in the 
astrocyte endfeet in contact with blood vessels, peaking at 1h after stroke onset in a 
model of transient occlusion of the middle cerebral artery (de Castro Ribeiro et al., 2006, 
Hirt et al., 2009). These early changes are associated with the development of ionic brain 
edema (Figure 1B) and the swelling of the astrocyte processes in stroke models (Risher et 
al., 2009). However, increased AQP4 expression is not observed in more severe stroke 
models (Friedman et al., 2009), prompting the hypothesis that under great tissue duress, 
the brain is not able to synthesize sufficient new AQP4 proteins during the early phase of 
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reperfusion. Interestingly, in stroke, the ratio of AQP4-m1 and AQP4-m23 is changed in 
the ischemic hemisphere, with higher induction of AQP4-m1 compared to AQP4-m23 
(Hirt et al., 2009), suggesting a disorganization of the OAPs in accordance with previous 
rat stroke data (Suzuki et al., 1984). However, the functional consequences of AQP4-m1 
increase and disorganization in stroke are not yet elucidated (Figure 1A) and in our jTBI 
model there was no significant difference in the ratio between AQP4-m1 compared to 
AQP4-m23 between sham and jTBI animals (Fukuda et al., 2012). 
The complexity of the role of AQP4 in edema process is outlined by the variety of 
the changes in AQP4 expression, which seems to depend on both the degree of severity 
and the pathological model. Indeed, increased AQP4 (Sun et al., 2003, Guo et al., 2006, 
Ding et al., 2009, Higashida et al., 2011, Tomura et al., 2011) versus decreased AQP4 
(Ke et al., 2001, Kiening et al., 2002, Zhao et al., 2005) are likely due to differences in 
injury type, rodent strains, and age at impact (Fukuda et al., 2012). Moreover, several 
studies using the AQP4-/- mice showed discrepancies in the outcomes and interpretation 
of the role of AQP4 in edema process. For example, AQP4-/- mice reveal a protective 
role for AQP4 in spinal cord injury models with a decrease of edema formation and 
lesion size at early time point after injury (Saadoun et al., 2010). Using a similar model 
and transgenic mice, a second set of experiments showed functional improvement for the 
WT mice compared to the AQP4-/- mice at longterm after contusion spinal cord injury 
(Kimura et al., 2010), suggesting that AQP4 either plays detrimental roles in the edema 
process or a protective role by facilitating the clearance of excess water. Several other 
contradictory results using the non-conditional AQP4-/- mice (Saadoun et al., 2008, 
Kimura et al., 2010), indicate the limitations of using this genetic tool to solve the 
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question of the pathophysiological role of AQP4 in edema formation. In our lab, we 
recently developed in vivo application of siRNA targeting AQP4 (siAQP4), showing 
specific AQP4 decrease with reduced water mobility (Badaut et al., 2011a, Fukuda et al., 
2013, in press). This new tool is further developed as a molecular approach to address the 
question of the role of AQP4 in edema formation, which was tested in a model of 
juvenile traumatic brain injury (jTBI). In this model we showed that AQP4 expression is 
not changed at 24h during the build-up of edema (Fukuda et al., 2012). Our results 
suggest that stable AQP4 levels may contribute to water entry leading to cellular swelling 
(lower apparent diffusion coefficient (ADC)) and increased edema (increased T2) at 
proximity of the site of impact (Fukuda et al., 2012). Interestingly, application of siAQP4 
after jTBI induced a reduction in edema formation associated with cognitive 
improvement at 2 months post-injury, suggesting that siAQP4 could be used as a specific 
drug to prevent edema formation by transiently decreasing the level of AQP4 expression 
(Fukuda et al., 2013, in press). This data show that the presence of AQP4 plays a 
deleterious role during the edema formation by facilitating the entry of water in the 
astrocytes. 
  
Edema Resolution in Acute Brain Disease:  
Role of AQP in Water Clearance 
 
As mentioned previously, the data generated using AQP4-/- mice raised the 
hypothesis of a dual role for AQP4 in the edema process with a deleterious role of AQP4 
in edema build-up and its beneficial role in water clearance during the edema resolution 
(Saadoun and Papadopoulos, Papadopoulos et al., 2004). Despite the lack of a clear 
answer on the role of AQP4 in edema resolution, several results support this hypothesis. 
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The first evidence is the infusion of saline solution in brain parenchyma that induced 
significant increase in the intracranial pressure in AQP4-/- mice compared to the WT 
(Papadopoulos et al., 2004). In several pathological conditions, increased AQP4 was 
observed to be associated with edema resolution measured over time using MRI (Meng et 
al., 2004, Tourdias et al., 2009, Badaut et al., 2011a, Badaut et al., 2011b, Tourdias et al., 
2011, Fukuda et al., 2012, Fukuda et al., 2013, in press). Frequently, AQP4 expression is 
increased after 48h in stroke models (de Castro Ribeiro et al., 2006, Hirt et al., 2009), in 
TBI (Sun et al., 2003, Guo et al., 2006, Ding et al., 2009, Higashida et al., 2011, Tomura 
et al., 2011, Fukuda et al., 2012) and in neuroinflammatory lesion conditions (Tourdias et 
al., 2011). Most of the time, the increase of the AQP4 is observed near the lesion site in 
perivascular astrocyte endfeet, astrocyte processes, and the glia limitans (de Castro 
Ribeiro et al., 2006, Fukuda et al., 2012). These changes may indicate that excess AQP4 
could facilitate edematous fluid elimination through the subarachnoid space (Fernandez-
Teruel et al., 2002, Nicchia et al., 2009, Tourdias et al., 2011). As observed in a jTBI 
model, increased AQP4 in the glia limitans may compensate for water accumulation at 1 
and 3 days (higher T2), with a gradual increase of AQP4 at 3 days and normalization of 
both AQP4 and T2 values by 7 days (Fukuda et al., 2012). In the rat neuroinflammatory 
lesion model, the ADC monitored time course study indicates a clear distinction between 
a minor AQP4 expression increase during the edema build-up phase and a shift to strong 
AQP4 expression during the edema resolution phase (Tourdias et al., 2011). In fact, ADC 
values are significantly increased when AQP4 expression is at the peak of its expression 
(Tourdias et al., 2011). 
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Neuroinflammation in Brain Injury:  
Astrocytic AQP4 
 
AQP4 expression is frequently increased during the onset of neuroinflammatory 
period characterized by microglia activation and astrogliosis. In fact, several interesting 
recent data suggest a potential relationship between AQP4 and microglial activation, 
without a clear definition about the link. First, AQP4-/- mice are more vulnerable to 
seizures compared to WT one month after TBI (Lu et al., 2011). This difference was 
explained by the neuroinflammatory response showing less astrogliosis and increased 
microglial activation in AQP4-/- compared to WT mice. Minocycline injection in AQP4-
/- reversed the outcome by inhibition of the increase in microglia activation and 
decreased the severity of post-traumatic seizures (Lu et al., 2011). Similar results were 
reported in cryo-injury models, where AQP4-/- mice presented increased microglia and 
reduced astrogliosis compared to WT. In this model, a decrease in the lesion volume and 
in neuronal loss in AQP4-/- mice compared to WT was reported at 1 day after injury 
whereas the opposite result was reported at 7 and 14 days (Saubamea et al., 2012). In our 
lab, we have also observed that the siAQP4 treatment after jTBI showed a decrease in 
AQP4 associated with less BBB disruption, less edema, more NeuN positive cells, and 
better behavior outcomes compared to the control group up to 2 months post-injury 
(Fukuda et al., 2013). As observed in the AQP4-/- mice, we reported an increase in 
activated microglia and a decrease in astrogliosis around the lesion at 3 days post-injury 
in siAQP4 treated rats compared to control group. However, this difference is not present 
anymore at 2 months post-injury (Fukuda et al., 2013). One possible explanation for this 
observation may be that changes in AQP4 expression are associated with changes in 
astrogliosis and microglia activation in acute brain injury. Astrogliosis may require the 
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presence of AQP4 to facilitate the water movement necessary for migration (Saadoun et 
al., 2005, Auguste et al., 2007) and hypertrophy. However, the mechanism behind the 
decrease of the AQP4 and activation of microglia is still unknown. One possible 
mechanism is a modification in the pattern of cytokine release in response to astrocytic 
AQP4 down regulation or inhibition. The other hypothesis is in relation with the presence 
of stretch-activated chloride (Cl
-
) channels expressed in microglia and known to be 
activated by osmotic stress (Lewis et al., 1993, Eder et al., 1998, Schlichter et al., 2011). 
The activation of these channels contributes to the maintenance of the non-activated 
(ramified) phenotype of microglia (Eder et al., 1998). Because AQP4 is responsible for 
water transport and osmotic pressure, we can hypothesize that inhibition of AQP4 either 
through genetic deletion or siRNA will modify the osmotic stress within the extracellular 
space surrounding the microglia. This would change the activation status of the swelling 
activated chloride channels, resulting in microglia activation. Another possibility lies in 
the cross talk that occurs between astrogliosis and microglia activation (Liu et al., 2011). 
The decrease of reactive astrogliosis as a result of the absence of AQP4 may cause an 
increase in microglial activity. The exact link between microglial activation and 
decreased astrogliosis in absence of AQP4 needs further investigation. However, it is 
likely that at 3 days post-jTBI, increased microglia activation due to siAQP4 treatment is 
contributing to the beneficial effects observed on the cognitive outcome. Indeed, acute 
microglia activation was hypothesized to be beneficial in contrast to chronic microglia 
activation (Loane and Byrnes, 2010). These changes of AQP4 in relation with 
neuroinflammation could also be correlated with imaging signal changes over time after 
brain injury or in chronic brain disorders. 
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Future Developments: Drugs Against AQP4? 
As mentioned previously, there is no specific inhibitor to block the AQP4 channel 
and such a compound is critical for evaluating the role of AQP4 and treatment of edema. 
Using siRNA strategy permitted to show the potential to use a specific inhibitor of AQP4 
in jTBI and the contribution of astrocytic AQP4 in neuroimaging (Manley et al., 2000, 
Fukuda et al., 2013, in press). Although non-specific, a range of compounds already 
commercially available that may block AQP4 have been tested. Bumetanide blocks the 
AQP4 channel and water permeability in oocytes (Migliati et al., 2009), and bumetanide 
prevents edema formation after brain ischemia (O'Donnell et al., 2004, Migliati et al.), 
which correlates with decreased AQP4 expression (Migliati et al.). However bumetanide 
is also an inhibitor of Na-Cl-K co-transporter expressed in endothelial cells. This multiple 
site of action of bumetanide is complicating in vivo validation and makes teasing out solo 
effects of AQP4 difficult (O'Donnell et al., 2004). Therefore the benefits of bumetanide 
on edema could also be due to the inhibition of Na-Cl-K co transporter expressed in 
endothelial cells. Acetazolamide (AZA), a sulfonamide carbonic anhydrase inhibitor was 
also proposed for a specific inhibitor of water permeability associated with AQP1 and 
AQP4 (Huber et al., 2007, Tanimura et al., 2009). However, it was reported that AZA has 
no effect on water permeability (Sogaard and Zeuthen, 2008, Yang et al., 2008). 
Similarly, two other inhibitors belonging to sulfonamide carbonic anhydrase inhibitor 
class, methazolamide and valproic acid have also been tested but without clear effects on 
the water permeability (Huber et al., 2009, Tanimura et al., 2009). Waiting to have a 
specific pharmacological drug to block AQP4, the siRNA strategy was used with success 
in normal brain to silence the AQP4 expression (Badaut et al., 2011a). Decrease of AQP4 
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is associated with a decrease of ADC values (Badaut et al., 2011a). siAQP4 was used as 
treatment in jTBI with decrease of the edema formation post-TBI and functional 
improvement up to 2 months post-injury (Fukuda et al., 2013, in press). These results 
encourage us to use the siRNA strategy as a specific drug to prevent the edema 
formation. However, heterogeneous alterations in AQP4 expression demonstrate the 
complexity of modifying edema reduction. This strongly suggests testing the siAQP4 
treatment strategy in different brain disorder models to find out which battles will be won 
with siRNA, and which ones should be avoided. 
 
Connexin 43: Consideration of Potential Post Injury  
Cascade other than Edema Formation 
 
 In our hypothesized model before conducting the studies, AQP4 was thought of as 
the initial passage into the astrocyte network entering/exiting the network. Cx43, on the 
other hand, was thought to be the passageway between astrocytes within the network. We 
thought that siRNA against either protein would decrease edema formation and result in 
beneficial outcome after jTBI. However, unlike siAQP4 treatment, siCx43 did not result 
in changes in the edema process after jTBI.  But although the edema process did not seem 
to be altered with siCx43, nevertheless, siCx43 animals did perform better in the foot 
fault test compared to control.  
Thus we speculate that Cx43 most likely plays a role in the injury cascade of jTBI 
other than edema. In order to shed light onto possible non-edematous roles of Cx43, it is 
important to consider the functions of non-gap junction forming, or uncoupled, 
hemichannels; which do not participate in intracellular trafficking of molecules, but 
rather between the astrocyte and the extracellular environment (Goodenough and Paul, 
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2003). Eugenin et al. has an excellent review which contains a section on Cx43 astroglial 
hemichannels (Eugenin et al., 2012). Under normal condition, uncoupled Cx43 
hemichannels remain closed but a variety of pathological triggers such as metabolic 
inhibition, fibroblast growth factor 1, hypoxic condition, ischemic condition, oxidative 
stress, increased calcium concentration, and acidic environment can open the 
hemichannel, leading to release of ATP, glutamate, NADH out to the extracellular space 
(Contreras et al., 2002, Bennett et al., 2012, Eugenin et al., 2012, Kar et al., 2012). This 
release increases neurotoxicity and neuronal susceptibility to insult, leading to pro-
inflammatory cytokine induced neuronal cell death (Froger et al., 2010, Orellana et al., 
2011). At this point, it is also important to remember that one of the key hallmarks of 
injury after brain injury is reactive astrogliosis, which modulates production of pro-
inflammatory cytokines (Anderson et al., 2014). Cx43 KO animal has been shown to 
have decreased astrogliosis and decreased proliferation of astrogliosis after ischemia as 
well (Nakase et al., 2004). Alas, some pathological functions that have been associated 
with Cx43 upregulation are apoptosis, excitotoxicity, and neuroinflammation (Bennett et 
al., 2012), and these functions could be explained by opening of uncoupled 
hemichannels. In our model, we also observed the siCx43 resulted in a decreased post-
injury reactive astrogliosis as interpreted via decreased GFAP immunofluorescence 
intensity (Ch. 4). Thus, in future studies, the potential effect of siCx43 after jTBI on other 
mechanisms can be studied such as caspase-3 for apoptosis, NeuN for neuronal survival 
and IBA for microglial activation as performed in our earlier AQP4 studies (Fukuda et 
al., 2013). 
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 Additionally, it is also important to consider the potential role and function of the 
other astrocyte gap junction forming connexin: Cx30. Because Cx30 was discovered in 
astrocytes later than Cx43 (Nagy et al., 1997, Nagy et al., 1999), Cx43 has been studied 
in more extensive detail than Cx30 as the main astrocyte connexin. Thus, Cx30’s specific 
functions in the brain are still largely unknown, although Cx30 has been shown to have a 
functional role in controlling cellular membrane integrity in the inner ear (Schutz et al., 
2010, Forge et al., 2013) and glutamate clearance (Pannasch et al., 2014). However, a 
study which compared a Cx43 KO to Cx30 KO to a Cx43/30 Double KO showed that the 
double KO mice had white matter intramyelinic edema and astrocyte edema in the CA1 
but the single allele deletions did not have any edema, potentially signifying that Cx43 
and Cx30 may have redundant roles and may compensate each other in situations where 
one protein is decreased (Lutz et al., 2009). Additionally Cx43/30 Double KO also 
showed a weakened state of BBB as well, which could lead to increased vasogenic edema 
under stress and insult such as jTBI (Ezan et al., 2012). Thus, it is possible that Cx43 and 
Cx30 both have overlapping roles regarding water homeostasis and the edema process, 
therefore siCx43 alone did not cause a change in T2 and ADC value due to Cx30 
compensation. 
And lastly, future studies can better elucidate the potential relationship that AQP4 
and Cx43 and Cx30 may have on each other under normal and pathological conditions. 
Interestingly, a decrease in Cx43 protein expression and a concomitant decrease in gap 
junction function after administration of siRNA against AQP4 in primary astrocyte 
culture have been reported (Nicchia et al., 2005). Another brain cell cultures taken from 
AQP4 -/- mice have also shown lower Cx43 protein level compared to wildtype (Kong et 
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al., 2008). A transgenic mice lacking Cx43 and Cx30 have also been reported to have 
decreased AQP4 levels (Ezan et al., 2012). 
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